Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1050.Time spend outdoors in summer,39305,0.0368903927793005,0.0255215499235837,-0.0131318450709235,0.0869126306295245,0.148336550968118
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1060.Time spent outdoors in winter,34284,0.0195875231338576,0.0288086762228355,-0.0368774822629,0.0760525285306151,0.496561292638927
CCND2,G1/S-specific cyclin-D2,Physical activities,X1070.Time spent watching television (TV),41388,-0.0420568116630803,0.0256539513501729,-0.0923385563094192,0.00822493298325859,0.101139825255682
CCND2,G1/S-specific cyclin-D2,Physical activities,X1080.Time spent using computer,34303,-0.104839234365447,0.0265559397114897,-0.156888876199967,-0.0527895925309271,7.90089356801571e-05
CCND2,G1/S-specific cyclin-D2,Physical activities,X1090.Time spent driving,29783,-0.0285189650459741,0.0293053606139395,-0.0859574718492955,0.0289195417573473,0.330478976715475
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1160.Sleep duration,43580,-0.0299965260391518,0.0233959703546632,-0.0758526279342917,0.0158595758559881,0.199806109460002
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,14214,0.000812941030236263,0.0104351757959098,-0.0196400035297469,0.0212658855902194,0.93790558416175
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,14214,-6.48415454495248e-05,0.0101662121203804,-0.0199906173013952,0.0198609342104961,0.994911102997952
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,14214,0.0158974103783687,0.0115130791951144,-0.00666822484405543,0.0384630456007928,0.167358171216577
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,14214,0.00915099251183164,0.0117792014689727,-0.0139362423673549,0.0322382273910182,0.437244192123123
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,14214,-0.00072309577839977,0.0119453848700062,-0.024136050123612,0.0226898585668125,0.951731599270831
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,14214,-0.00502065454594412,0.0255949190955123,-0.0551866959731483,0.0451453868812601,0.844489111582751
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,14214,-0.0145886175031439,0.0262170489185899,-0.0659740333835802,0.0367967983772923,0.577908368728099
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,14214,0.0073164148139834,0.0182960145963602,-0.0285437737948827,0.0431766034228495,0.689242685861613
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,14214,-0.0112697736501219,0.0135219896894282,-0.0377728734414012,0.0152333261411573,0.40461036811608
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,14214,0.00110823769408985,0.00918475499137916,-0.0168938820890133,0.019110357477193,0.903961605232883
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,14214,0.0143151293705286,0.0132880053352451,-0.0117293610865518,0.0403596198276089,0.281365866520489
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,14214,0.00252296764348262,0.00745163739509095,-0.0120822416508956,0.0171281769378609,0.73493194043231
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,14214,-0.0134011689843543,0.00956665264752625,-0.0321518081735057,0.00534947020479717,0.161289426060172
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,14214,-0.00372398314762482,0.0141404032277513,-0.0314391734740173,0.0239912071787677,0.79227876207687
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,14214,-0.0118733147339778,0.0132593106612412,-0.0378615636300106,0.014114934162055,0.370551081881967
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,14214,0.0180410175435461,0.0176768169932574,-0.0166055437632384,0.0526875788503306,0.30745981833501
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,14214,-0.0146602445074057,0.0170022944423552,-0.0479847416144219,0.0186642525996105,0.388563999857721
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,14214,0.00521801443294476,0.010417780647638,-0.0152008356364258,0.0256368645023153,0.616466283699905
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,14214,-0.000301295156828292,0.00983841578716441,-0.0195845900996705,0.0189819997860139,0.975569547611461
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,14214,0.00598722095387165,0.0122995463006109,-0.0181198897953257,0.030094331703069,0.626419003519175
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120040.Fatigue severity over the past week,14228,-0.0811603821593224,0.0421866221956654,-0.163846161662827,0.00152539734418188,0.0543943796476327
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120041.Waking unrefreshed severity over the past week,14229,-0.0594153601339477,0.0420600684158354,-0.141853094228985,0.0230223739610897,0.157786119885073
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120042.Cognitive symptoms severity over the past week,14227,0.0501979058449363,0.0456625265404944,-0.0393006461744327,0.139696457864305,0.271645442811542
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120098.Mobility problems today,14235,-0.0520346606585575,0.0495015680539495,-0.149057734044298,0.0449884127271834,0.29319748110683
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120099.Self-care problems today,14235,-0.0221814794353906,0.0763300742762793,-0.171788425016898,0.127425466146117,0.771361900823498
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120100.Problems doing usual activities,14235,-0.0609028079893726,0.0472682623256461,-0.153548602147639,0.0317429861688937,0.197610215789643
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120101.Pain or discomfort today,14235,0.0223324913088358,0.0422820750650995,-0.0605403758187592,0.105205358436431,0.597383557063876
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120102.Anxiety or depression today,14235,0.00416524580461494,0.0514251732758366,-0.0966280938160247,0.104958585425255,0.935446080782857
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120103.Scale to indicate how health is today,14184,0.00174617545013889,0.00321404132421618,-0.00455334554532481,0.0080456964456026,0.586934638027934
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,14197,0.0195602191315323,0.0521572653592079,-0.0826680209725152,0.12178845923558,0.707648328055911
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",14172,-0.0735284377577581,0.0533763968338159,-0.178146175552037,0.0310893000365211,0.16836530525985
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",14207,0.00251421416468087,0.0421203027360441,-0.0800415791979655,0.0850700075273273,0.952402369134924
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,14212,-0.0267016759080018,0.043259372326074,-0.111490045667107,0.0580866938511033,0.537082357551052
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,14216,0.031627950250372,0.0559552439279917,-0.0780443278484917,0.141300228349236,0.571921794428282
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120109.Feeling bad about self over the last two weeks,14176,0.0110522788789579,0.0564462315513125,-0.0995823349616145,0.12168689271953,0.844768039494898
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120110.Trouble concentrating over the last two weeks,14215,0.0166842570438209,0.0564970018922479,-0.0940498666649851,0.127418380752627,0.767759673372107
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,14200,-0.0671820902521878,0.08301645098662,-0.229894334185963,0.0955301536815874,0.4183778181834
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,14135,-0.0167039798530797,0.113340919153519,-0.238852181393978,0.205444221687818,0.882835621422172
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",9888,-0.0360110687553943,0.0578495722225099,-0.149396230311514,0.077374092800725,0.533630816295793
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,39346,-0.0253143619209347,0.0566055865088302,-0.136261311478242,0.0856325876363724,0.654728741263795
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,36718,-0.0152764262157625,0.0346450081449936,-0.08318064217995,0.0526277897484251,0.65925785477682
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1289.Cooked vegetable intake,42300,-0.0448622791139766,0.0244200313129862,-0.0927255404874297,0.00300098225947642,0.066200699661904
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,41172,-0.0130328912654073,0.0258296979637518,-0.0636590992743608,0.0375933167435462,0.613863571148691
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1309.Fresh fruit intake,42247,0.00592236853865699,0.0254676550478104,-0.0439942353550515,0.0558389724323655,0.816116089641742
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1319.Dried fruit intake,39930,0.00498766493132225,0.026295772762784,-0.0465520496837344,0.0565273795463788,0.849564352592149
CCND2,G1/S-specific cyclin-D2,Health and medical history,X134.Number of self-reported cancers,43958,0.0377770786852987,0.045584538748876,-0.0515686172624982,0.127122774633096,0.40726414236211
CCND2,G1/S-specific cyclin-D2,Health and medical history,X135.Number of self-reported non-cancer illnesses,43959,-0.0678205459796918,0.0243592115379587,-0.115564600594091,-0.0200764913652927,0.0053685391644881
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X136.Number of operations, self-reported",43959,-0.0334251058828648,0.0239750336092551,-0.0804161717570049,0.0135659599912753,0.163275423188654
CCND2,G1/S-specific cyclin-D2,Health and medical history,X137.Number of treatments or medications taken,43959,-0.0524416925471258,0.0238165965236762,-0.0991222217335311,-0.00576116336072053,0.0276777608848994
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1438.Bread intake,42680,0.00634459741178779,0.00193994160327034,0.00254231186937793,0.0101468829541977,0.0010743903746398
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1458.Cereal intake,41730,0.0188545774061573,0.0241707231129125,-0.0285200398951513,0.0662291947074659,0.435360882980681
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1488.Tea intake,42406,0.00229141377859151,0.00185722823828121,-0.00134875356843966,0.00593158112562268,0.21729118773199
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1498.Coffee intake,40534,0.01597445935919,0.0242563464443638,-0.0315679796717631,0.063516898390143,0.510176805919518
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1528.Water intake,40703,-0.0190243901512073,0.0246781482112858,-0.0673935606453275,0.0293447803429128,0.440770546738247
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1568.Average weekly red wine intake,29889,-0.0960259506477778,0.0282613721854338,-0.151418240131228,-0.0406336611643275,0.000680234133276144
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,29883,-0.021593810602891,0.0290435433449895,-0.0785191555590704,0.0353315343532884,0.457186200781367
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1588.Average weekly beer plus cider intake,29963,-0.00745485158605841,0.0321963596490527,-0.0705597164982018,0.0556500133260849,0.816894327157313
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1598.Average weekly spirits intake,29841,0.0252035137420009,0.0312507889333649,-0.0360480325673943,0.0864550600513961,0.419965603773744
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1608.Average weekly fortified wine intake,29940,0.0730696977869664,0.0517995832326001,-0.0284574853489297,0.174596880922863,0.158366119435339
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1737.Childhood sunburn occasions,32933,-0.0432805099456116,0.028894493292182,-0.0999137167982883,0.0133526969070651,0.13417378254238
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1807.Father's age at death,32469,-0.000435390761592596,0.00213376032757801,-0.00461756100364549,0.0037467794804603,0.838316816685294
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1845.Mother's age,16692,-0.00533853589808767,0.00494121833596666,-0.0150233238365823,0.00434625204040699,0.279975790452643
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1873.Number of full brothers,43168,0.0153146493445032,0.0234487282844466,-0.0306448580930122,0.0612741567820186,0.513687459430559
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1883.Number of full sisters,43173,-0.00397483187207346,0.0235111684629287,-0.0500567220594138,0.0421070583152669,0.865749111175626
CCND2,G1/S-specific cyclin-D2,Physical measures,X20015.Sitting height,43614,-0.00260979484798392,0.00243846280439422,-0.00738918194459659,0.00216959224862875,0.284507176459574
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20016.Fluid intelligence score,14289,-0.0413545199829214,0.0400119928452251,-0.119778025959563,0.0370689859937197,0.301362649656639
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20018.Prospective memory result,14878,-0.0369621903589097,0.0524837785776161,-0.139830396371037,0.0659060156532179,0.481282327157818
CCND2,G1/S-specific cyclin-D2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),14087,-0.00163623310004898,0.00324359491773826,-0.00799367913881597,0.00472121293871802,0.61395273149728
CCND2,G1/S-specific cyclin-D2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),14074,-0.000701100339825894,0.0032369118668981,-0.00704544759894617,0.00564324691929439,0.828526784617275
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20023.Mean time to correctly identify matches,43434,-0.00013571335084623,0.0019643531486205,-0.00398584552214241,0.00371441882044995,0.944919842127375
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#1.Illnesses of father_Heart disease,38262,-0.00142550769896374,0.00419166323058806,-0.00964116763091635,0.00679015223298886,0.73379691655443
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,37524,0.00477482180253022,0.00920174447623325,-0.013260597370887,0.0228102409759474,0.603830765662915
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,37463,0.00355204356688122,0.0123684933254593,-0.020690203351019,0.0277942904847815,0.773972395493491
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#12.Illnesses of father_Severe depression,37498,-0.0146025588259449,0.0104030514227576,-0.0349925396145498,0.00578742196266005,0.160422341687048
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,37527,0.0171353067024218,0.0074205338085575,0.00259106043764905,0.0316795529671945,0.0209393111253577
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#2.Illnesses of father_Stroke,37802,0.00928467116804779,0.00539348917419704,-0.00128656761337841,0.019855909949474,0.0851757273794252
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,37709,-0.00925864419993921,0.00682315294011028,-0.0226320239625553,0.00411473556267693,0.174806768795664
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,37535,-0.0101487278010539,0.00852233893441422,-0.0268525121125057,0.00655505651039801,0.233724594681328
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,37795,0.00345111211137632,0.00623658438369671,-0.00877259328066922,0.0156748175034219,0.580016270397054
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,37903,0.00640539905682519,0.00470596449034329,-0.00281829134424767,0.015629089457898,0.173482745899216
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#9.Illnesses of father_Diabetes,37667,0.0209476837864217,0.00650682060002039,0.00819431541038172,0.0337010521624617,0.00128593821025571
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,40054,-0.00474046025417256,0.00479093499545313,-0.0141306928452607,0.00464977233691558,0.322441893899933
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,39812,-0.00618011883593838,0.00689180852641874,-0.0196880635477191,0.00732782587584234,0.369866312369045
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,39686,-0.0259069789647083,0.0152001509127115,-0.0556992747536228,0.00388531682420622,0.0883161579590586
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,39749,0.00656450210093927,0.00770475776427621,-0.0085368231170421,0.0216658273189206,0.394215734264523
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#2.Illnesses of mother_Stroke,39953,0.00181325631276418,0.00546694193412006,-0.00890194987811114,0.0125284625036395,0.74013526751998
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,39767,-0.00475912225454198,0.0096852505294667,-0.0237422132922967,0.0142239687832128,0.623161599128266
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,39735,-0.00673924491281203,0.00863524450761669,-0.0236643241477407,0.0101858343221167,0.435139669311752
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,39769,0.00332464604688243,0.00707832924090263,-0.0105488792652867,0.0171981713590516,0.638576506696765
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,39817,0.00131698996206915,0.00809131709451071,-0.0145419915431718,0.0171759714673101,0.870703637542222
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,40141,-0.00336973995690754,0.00414852477764093,-0.0115008485210838,0.00476136860726869,0.41663908682392
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,39880,0.00175335605273155,0.00640477792129833,-0.0108000086730132,0.0143067207784763,0.784272397310196
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,34405,-0.00227964924978447,0.00673566594030137,-0.0154815544927752,0.0109222559932062,0.735030292728564
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,34153,-0.0319216491102149,0.0269065952739608,-0.084658575847178,0.0208152776267482,0.235477550215298
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,34147,-0.0166327858198689,0.0271498401784847,-0.069846472569699,0.0365809009299612,0.540125604383183
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,34253,-0.000446849806114981,0.00797934421910631,-0.0160863644755633,0.0151926648633334,0.955341482003453
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,34170,0.00973056939594495,0.0157924400595284,-0.0212226131207307,0.0406837519126206,0.537797229983344
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,34215,-0.0059550139339325,0.0113158282692734,-0.0281340373417084,0.0162240094738434,0.598714289516979
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,34172,-0.00447432868143259,0.0134228056681894,-0.0307830277910839,0.0218343704282187,0.738881345485442
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,34176,-0.0224094407020569,0.013179786546866,-0.0482418223339141,0.00342294092980043,0.0890857575963621
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,34197,-0.00501073979993792,0.00985869876127661,-0.0243337893720401,0.0143123097721642,0.611277315794243
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,34219,0.00918257931441143,0.0122489742478569,-0.0148254102113882,0.033190568840211,0.453464006997497
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,34521,-0.00430496738552268,0.00503676081026493,-0.0141770185736419,0.00556708380259659,0.392717915912445
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,34336,-0.0101788056982013,0.00711576091554702,-0.0241256970926735,0.00376808569627084,0.152594370038948
CCND2,G1/S-specific cyclin-D2,Mental health,X20127.Neuroticism score,34906,0.0513520168527048,0.0245113040761412,0.00330986086346797,0.0993941728419416,0.0361751581099096
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,14289,-0.0544576205193467,0.0403820696717783,-0.133606477076032,0.0246912360373389,0.177499932499695
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20161.Pack years of smoking,13513,-0.00245551294130798,0.00359853782684261,-0.00950864708191949,0.00459762119930353,0.495020473595071
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,13513,-0.00226349718622862,0.00354721216778771,-0.00921603303509254,0.00468903866263529,0.523415538597925
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20191.Fluid intelligence score,10598,0.0637527985451564,0.0442087283014733,-0.0228963089257312,0.150401906016044,0.149307670072842
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,10599,0.0166377648425735,0.0452574456356418,-0.0720668286032844,0.105342358288431,0.713160288924953
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20240.Maximum digits remembered correctly,9513,-0.0464903239655339,0.0476467072746216,-0.139877870223792,0.0468972222927245,0.329223125896335
CCND2,G1/S-specific cyclin-D2,Physical measures,X20255.Spirometry QC measure,32604,-0.0194703631700559,0.030976232355948,-0.080183778587714,0.0412430522476022,0.529642773428378
CCND2,G1/S-specific cyclin-D2,Eye measures,X20261.avMSE,9779,-0.00382988439305498,0.00384861890201667,-0.0113731774410076,0.00371340865489769,0.319696654989919
CCND2,G1/S-specific cyclin-D2,Eye measures,X20262.Myopia diagnosis,9779,0.0341248146999144,0.060222756359382,-0.0839117877644743,0.152161417164303,0.570969650503418
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20280.Glucose-lactate,24386,0.000482511966113846,0.00250237208729087,-0.00442213732497625,0.00538716125720395,0.847100112816652
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20281.Spectrometer-corrected alanine,24436,-0.00849691320120938,0.00251274495229029,-0.0134218933076983,-0.00357193309472041,0.000721973155056959
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,13700,-0.000713072920404574,0.0130409972697716,-0.026273427569157,0.0248472817283478,0.956394739565886
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,13698,0.0185999110323437,0.0255436424215828,-0.0314656281139587,0.068665450178646,0.466526853403074
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),13699,0.0200251587275661,0.0319637303723149,-0.0426237528021711,0.0826740702573033,0.530999914668307
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),13699,-0.0156402783144226,0.0123991031878436,-0.039942520562596,0.00866196393375074,0.207184830242049
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),13699,0.024030286255975,0.0213690460412146,-0.0178530439848056,0.0659136164967555,0.260804940808107
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,13706,-0.0593782567463289,0.0274427669790816,-0.113166080025329,-0.00559043346732904,0.0305036633202662
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,13706,-0.0129047215458957,0.0181279726684107,-0.0484355479759807,0.0226261048841893,0.476558719803794
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,13706,-0.000883001329477278,0.0201768200655719,-0.0404295686579982,0.0386635659990436,0.965093834136304
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,13706,-0.0132164117255408,0.0312895292278548,-0.0745438890121362,0.0481110655610546,0.672746367488806
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,13706,-0.0470530060686577,0.0360818483679868,-0.117773428869912,0.0236674167325963,0.192234000230038
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,13706,-0.0024389461843022,0.021316591688291,-0.0442194658933526,0.0393415735247482,0.908910191076184
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,13706,-0.0449823618469011,0.0357687688385608,-0.11508914877048,0.0251244250766782,0.2085623714974
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,13706,-0.0363721534929931,0.0263331688243132,-0.0879851643886469,0.0152408574026607,0.167230902169509
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),13709,-0.0178215890127675,0.0365760084856966,-0.0895105656447329,0.0538673876191979,0.626090352659952
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),13709,0.00107998645338928,0.0167045170377788,-0.0316608669406571,0.0338208398474357,0.948451738056445
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),13709,-0.00471592973687354,0.0248167857079172,-0.0533568297243912,0.0439249702506441,0.849288566600032
CCND2,G1/S-specific cyclin-D2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,13710,0.0276434191696169,0.0427662218428317,-0.0561783756423333,0.111465213981567,0.518041263691718
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20600.Liking for adding salt to foods,15511,-0.0577917871652488,0.0368246164602008,-0.129968035427242,0.0143844610967447,0.116580035711326
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20601.Liking for aniseed,15511,-0.0394088298241521,0.0368096297892696,-0.111555704211121,0.0327380445628163,0.284360627841756
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20602.Liking for apple juice,15511,0.00890290210182037,0.0364728166046371,-0.0625838184432684,0.0803896226469091,0.807158993172749
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20603.Liking for apples,15511,0.0653534938804701,0.0371505685697888,-0.00746162051631598,0.138168608277256,0.0785714519588504
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20604.Liking for asparagus,15511,-0.00273186304677731,0.0376775968024634,-0.0765799527796055,0.0711162266860509,0.942199930150338
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20605.Liking for aubergine,15511,-0.0313524763277763,0.0366507450602626,-0.103187936645891,0.0404829839903384,0.392321399376865
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20606.Liking for avocados,15511,-0.0142474519191614,0.0371757011326974,-0.0871118261392483,0.0586169223009254,0.701542371285706
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20607.Liking for bacon,15511,0.0161208794573593,0.0368711645062635,-0.0561466029749173,0.0883883618896358,0.661956547281087
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20608.Liking for baked or steamed fish,15511,0.0399199440317183,0.0370197978120821,-0.0326388596799625,0.112478747743399,0.280898662459199
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20609.Liking for bananas,15511,0.0472641320054968,0.0376900564102661,-0.0266083785586249,0.121136642569618,0.20985320481305
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,15511,-0.0231157862422855,0.0366696415099188,-0.0949882836017264,0.0487567111171555,0.528455692512542
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20611.Liking for beef steak,15511,-0.0573090069874958,0.0368588161321629,-0.129552286606535,0.0149342726315436,0.120008197382036
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20612.Liking for beetroot,15511,0.0414405980367742,0.0375035546985759,-0.0320663691724346,0.114947565245983,0.269186342792712
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20613.Liking for bell pepper,15511,-0.0320711446746425,0.0370126738708689,-0.104615985461545,0.0404736961122604,0.386234443640074
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20614.Liking for bicycling,15511,-0.00371721152220014,0.037048641813243,-0.0763325494761564,0.0688981264317561,0.920081040752924
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20615.Liking for biscuits,15511,0.00553969842029137,0.0370502460745066,-0.0670787838857417,0.0781581807263244,0.881146433759865
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20616.Liking for bitter foods,15511,-0.0216574281166879,0.0369526733458324,-0.0940846678745193,0.0507698116411436,0.557826562574199
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20617.Liking for bitter or ale,15511,-0.0243059407614237,0.0377799543612162,-0.0983546513094075,0.0497427697865601,0.520002987959275
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20618.Liking for black olives,15511,-0.0142806357501092,0.0368505413499431,-0.0865076967959976,0.0579464252957793,0.698370300513315
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20619.Liking for black pepper,15511,0.0153018067580891,0.0369105753271257,-0.0570429208830773,0.0876465343992555,0.67846662981816
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20620.Liking for blue cheese,15511,-0.0265739790688486,0.036587805922114,-0.098286078676192,0.0451381205384948,0.467661573028668
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20621.Liking for bolognese sauce,15511,-0.0457700748677041,0.0372845104781975,-0.118847715404971,0.027307565669563,0.219619749523888
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20622.Liking for broad beans,15511,0.0438826607406875,0.037097669666967,-0.0288287718065678,0.116594093287943,0.23686878444728
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20623.Liking for broccoli,15511,0.0806156716776515,0.0376955329618485,0.00673242707242841,0.154498916282875,0.0324836635410223
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20624.Liking for brown rice,15511,0.0282547123107783,0.0367059622580544,-0.0436889737150085,0.100198398336565,0.441455129425216
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20625.Liking for brussel sprouts,15511,-0.0188689310757039,0.0368742066795414,-0.091142376167605,0.0534045140161971,0.608860697638713
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20626.Liking for burgers (meat),15511,-0.0183947189416714,0.0365425022722548,-0.0900180233952908,0.0532285855119481,0.614705171096131
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20627.Liking for burn of spicy foods,15511,0.00931282905336942,0.0363514174410409,-0.0619359491310707,0.0805616072378095,0.797808394327642
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20628.Liking for butter on bread,15511,0.0178101746031987,0.0372525878073521,-0.0552048974992113,0.0908252467056087,0.632591274980694
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20629.Liking for butternut squash,15511,-0.010073892159975,0.0366031913745308,-0.0818161472540554,0.0616683629341053,0.783151694726255
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20630.Liking for cabbage,15511,0.0111394202511793,0.0373814183913231,-0.0621281597958139,0.0844070002981725,0.76571211058619
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20631.Liking for cake,15511,0.104509409960335,0.0371202616567226,0.0317536971131592,0.177265122807512,0.00487738864425458
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20632.Liking for cake icing,15511,-0.00824160893065559,0.0366073558778026,-0.0799920264511487,0.0635088085898375,0.821876971846427
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20633.Liking for capers,15511,-0.0137917738067728,0.036286609877506,-0.0849135291666845,0.0573299815531388,0.703892079369139
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20634.Liking for cauliflower,15511,0.014843896928018,0.0375464144222752,-0.0587470753396415,0.0884348691956774,0.692591581991933
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20635.Liking for cereal or granola bar,15511,0.0472113864287736,0.0366728160299711,-0.0246673329899697,0.119090105847517,0.197985511863039
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20636.Liking for cheesecake,15511,0.0919772184940521,0.0368775668986434,0.019697187372711,0.164257249615393,0.0126371915015158
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20637.Liking for cherries,15511,0.0187644205819471,0.0383041396398797,-0.0563116931122172,0.0938405342761114,0.624225964527019
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20638.Liking for chicken,15511,0.0400174709249459,0.03884176714398,-0.0361123926772549,0.116147334527147,0.302899807195251
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20639.Liking for chilli pepper,15511,-0.0621723603519511,0.0367635338202786,-0.134228886639697,0.00988416593579494,0.090829782580806
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20640.Liking for chips or french fries,15511,0.0195964563834075,0.0368694703410055,-0.0526677054849633,0.0918606182517783,0.595073708749871
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20641.Liking for cigarette smoking,15511,-0.0772582414614167,0.0600829045236195,-0.195020734327711,0.0405042514048775,0.198510929749267
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20642.Liking for cod,15511,0.0345123656069932,0.0375647768772905,-0.0391145970724963,0.108139328286483,0.358244462230813
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20643.Liking for coffee with sugar,15511,0.0229995613211224,0.0401420578960779,-0.0556788721551902,0.101677994797435,0.566684011662874
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20644.Liking for coffee without sugar,15511,0.0106133558277358,0.0376781213688691,-0.0632357620552476,0.0844624737107193,0.778188938408354
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20645.Liking for coriander,15511,-0.020149013719193,0.0371929349028339,-0.0930471661287475,0.0527491386903615,0.588003326632548
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20646.Liking for corn flakes,15511,0.0468862959246032,0.0365850053660713,-0.0248203145928966,0.118592906442103,0.200012229792207
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20647.Liking for cream,15511,0.053108400910757,0.0368188861538314,-0.0190566159507524,0.125273417772266,0.149203356657694
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20648.Liking for croissant,15511,-0.00881742562027372,0.0365404902945682,-0.0804367865976274,0.06280193535708,0.809321450766321
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20649.Liking for cucumber,15511,0.0100242781719749,0.0374598836310323,-0.0633970937448485,0.0834456500887983,0.789010520703628
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20650.Liking for curry,15511,-0.0638377019817179,0.0370107798485428,-0.136378830484862,0.00870342652142601,0.0845761225639531
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20651.Liking for dairy products,15511,0.0804111664163633,0.0376211511894517,0.00667371008503803,0.154148622747689,0.0325816944148376
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20652.Liking for dark chocolate,15511,-0.0713697743142035,0.037421153160993,-0.14471523450975,0.00197568588134281,0.0565126514728701
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20653.Liking for diet fizzy drinks,15511,-0.0445124367019923,0.03789447503731,-0.11878560777512,0.0297607343711352,0.240156087508458
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20654.Liking for dried fruit,15511,0.0688481569779573,0.0371412964405156,-0.00394878404545333,0.141645098001368,0.0638036530299756
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20655.Liking for eggs,15511,-0.0244217041653389,0.0377798977475104,-0.0984703037504594,0.0496268954197815,0.518016581388553
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20656.Liking for exercising alone,15511,0.00430089570994626,0.0371684577475874,-0.068549281475325,0.0771510728952176,0.907881034871105
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20657.Liking for exercising with others,15511,0.0266710102737664,0.0369690975495425,-0.0457884209233369,0.0991304414708697,0.470649325750653
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20658.Liking for extra virgin olive oil,15511,-0.0306124141637612,0.037340443772399,-0.103799683957663,0.0425748556301409,0.412331778029714
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20659.Liking for fatty foods,15511,0.0195081124041315,0.0369911473096363,-0.0529945363227557,0.0920107611310187,0.597942517451094
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20660.Liking for fresh tomatoes,15511,0.0232665707089807,0.0391993409802139,-0.0535641376122384,0.1000972790302,0.552825180747012
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20661.Liking for fried chicken,15511,0.03799913842832,0.0364871724555343,-0.0335157195845272,0.109513996441167,0.297688436351921
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20662.Liking for fried or battered fish,15511,0.0420142866183402,0.0368532144360393,-0.0302180136762968,0.114246586912977,0.254285593146449
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20663.Liking for fruit,15511,0.0103809725637646,0.0411924544268272,-0.0703562381128166,0.0911181832403459,0.801035512514998
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20664.Liking for garlic,15511,-0.0347883718056695,0.0374045083451919,-0.108101208162246,0.0385244645509066,0.352355418066591
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20665.Liking for gherkins,15511,-0.0446328504006046,0.036334467573905,-0.115848406845458,0.0265827060442493,0.219319742880953
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20666.Liking for globe artichoke,15511,-0.0257304570278418,0.0371459683312894,-0.098536554957169,0.0470756409014854,0.488517607095097
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20667.Liking for goat's cheese,15511,-0.0152113280078737,0.0365401931925933,-0.0868301066653566,0.0564074506496091,0.677203357605878
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20668.Liking for going to a cafe,15511,-0.00788079503584936,0.0370082604767777,-0.0804169855703336,0.0646553954986348,0.8313711683426
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20669.Liking for going to the gym,15511,-0.0341639166338015,0.0367143406702379,-0.106124024347468,0.0377961910798647,0.352109533654263
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20670.Liking for going to the pub,15511,-0.0683201546771686,0.0370669789621642,-0.14097143344301,0.00433112408867323,0.0653256082155212
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20671.Liking for grapefruit,15511,0.0639554087305938,0.0363190720422641,-0.00722997247224387,0.135140789933431,0.0782696790574725
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20672.Liking for green olives,15511,-0.0113293478157108,0.0368893500472403,-0.0836324739083018,0.0609737782768802,0.758758420734504
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20673.Liking for haddock,15511,0.0416664873821442,0.0374440298494814,-0.0317238111228393,0.115056785887128,0.265825706402461
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20674.Liking for ham,15511,-0.00957753807686018,0.0369758825191348,-0.0820502678143643,0.062895191660644,0.795622312776501
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20675.Liking for hard cheese,15511,0.0281462461240159,0.0373470592279718,-0.0450539899628087,0.101346482210841,0.451076740005004
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20676.Liking for herring,15511,0.0565590536966025,0.0368016949385394,-0.0155722683829347,0.12869037577614,0.124348018736711
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20677.Liking for honey,15511,0.00689933030312321,0.0366629222519112,-0.0649599973106228,0.0787586579168692,0.85073584332403
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20678.Liking for horseradish or wasabi,15511,-0.0470314191480497,0.0364156317076834,-0.118406057295109,0.0243432189990097,0.196543625988588
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20679.Liking for ice cream,15511,0.0210041860692478,0.0367177272015813,-0.0509625592458515,0.0929709313843471,0.567299905186524
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20680.Liking for jam,15511,0.00492899574985338,0.0366483778778455,-0.0669018248907239,0.0767598163904306,0.893013512696025
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20681.Liking for kiwi fruit,15511,0.0125076909770098,0.0365715127057334,-0.0591724739262277,0.0841878558802473,0.732350725053802
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20682.Liking for lager,15511,-0.0385009515756703,0.0366092659438508,-0.110255112825618,0.0332532096742773,0.292966323508508
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20683.Liking for lamb,15511,-0.0287032259598719,0.037086218385025,-0.101392213994521,0.0439857620747771,0.438966636119775
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20684.Liking for lemons,15511,-0.0116715970330911,0.0366820231142928,-0.083568362337105,0.0602251682709228,0.750350399187308
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20685.Liking for lentils or beans,15511,-0.00240460449169454,0.0373006389424898,-0.0755138568189745,0.0707046478355855,0.948600405686777
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20686.Liking for liver,15511,0.00407323919917314,0.036755941650358,-0.0679684064355286,0.0761148848338749,0.911761691771972
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20687.Liking for mackerel,15511,0.0636834758009305,0.0369974595303041,-0.00883154487846542,0.136198496480327,0.085217601090063
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20688.Liking for marzipan,15511,0.0323892132096834,0.0365063122422481,-0.0391631587851229,0.10394158520449,0.374973021575584
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20689.Liking for mayonnaise,15511,-0.105656617482419,0.0366583600412248,-0.177507003163219,-0.0338062318016183,0.00395455567317491
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20690.Liking for melon,15511,-0.0489589496731724,0.0380059914187925,-0.123450692854006,0.0255327935076609,0.197698970458821
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20691.Liking for milk chocolate,15511,0.0742369040342227,0.0368584561703429,0.00199432994035066,0.146479478128095,0.0440154735493514
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20692.Liking for mushrooms,15511,-0.0115037069897714,0.0380318527609478,-0.086046138401229,0.0630387244216862,0.762293602976364
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20694.Liking for orange juice,15511,0.0415384195822265,0.0366938369306705,-0.0303815008018878,0.113458339966341,0.257640546830597
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20695.Liking for oranges,15511,0.0514362000077112,0.03779401705257,-0.022640073415326,0.125512473430748,0.173545676031517
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20696.Liking for pasta,15511,-0.00524923156969678,0.0372209127544726,-0.078202220568463,0.0677037574290694,0.887848793172876
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20697.Liking for pears,15511,0.0046883216186102,0.0375269233811547,-0.068864448208453,0.0782410914456734,0.90057883656725
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20698.Liking for pizza,15511,0.00655154518588321,0.0368076165689474,-0.0655913832892537,0.0786944736610201,0.858729796260228
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20699.Liking for plain yogurt,15511,0.0460784002787736,0.0373450298778622,-0.0271178582818363,0.119274658839383,0.217275179811058
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20700.Liking for plums,15511,0.0582250536071749,0.0373190992143926,-0.0149203808530345,0.131370488067384,0.118734354957893
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20701.Liking for pollock,15511,-0.00679340186946414,0.0365359176981477,-0.0784038005578336,0.0648169968189053,0.852496108930693
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20702.Liking for pork chop,15511,0.0253349418336633,0.0366286831479994,-0.0464572771364155,0.0971271608037421,0.489155292120617
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20703.Liking for porridge,15511,0.0536865775189629,0.0371142679506265,-0.0190573876642651,0.126430542702191,0.148051290935834
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20704.Liking for potato crisps,15511,0.0152452478621098,0.0372563902914069,-0.0577772771090477,0.0882677728332674,0.682399873277829
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20705.Liking for potatoes,15511,0.0301034835923178,0.0372094051853526,-0.0428269505709734,0.103033917755609,0.418510958482226
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20706.Liking for prawns,15511,0.00672632089458518,0.0371963660293765,-0.0661785565229927,0.0796311983121631,0.856501227758682
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20707.Liking for raw carrots,15511,-0.000195787319863732,0.0373770834752083,-0.073454870931272,0.0730632962915445,0.995820635821714
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20708.Liking for red meat,15511,-0.0378087395583522,0.0369262627986734,-0.110184214643752,0.0345667355270477,0.305899281177113
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20709.Liking for red wine,15511,-0.0571099233995663,0.0369969054016121,-0.129623857986726,0.0154040111875934,0.122695866427574
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,15511,-0.014863719741758,0.0380011990614432,-0.0893460699021867,0.0596186304186708,0.695700482858628
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20711.Liking for roast chicken,15511,0.0337302998400958,0.0388074810898676,-0.0423323630960447,0.109792962776236,0.384767601331983
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20712.Liking for salad dressing,15511,-0.0417343886854504,0.0364500618426925,-0.113176509897128,0.0297077325262269,0.252237443497154
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20713.Liking for salad leaves,15511,-0.00696833964272792,0.037754369248155,-0.0809669033691118,0.0670302240836559,0.853568408282659
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20714.Liking for salami,15511,0.00241679594584201,0.0364736067125358,-0.0690714732107281,0.0739050651024121,0.94717048843493
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20715.Liking for salmon,15511,0.0355638865683783,0.0386791781563032,-0.0402473026179759,0.111375075754733,0.357870291944888
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20716.Liking for salty foods,15511,-0.0628014703344322,0.036670535235239,-0.134675719395501,0.00907277872663632,0.0868086205833755
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20717.Liking for salty pretzels,15511,-0.0418219154703599,0.0369333628487342,-0.114211306653879,0.0305674757131591,0.257500044854678
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20718.Liking for sardines,15511,0.0193546898566514,0.0365680440335422,-0.0523186764490913,0.0910280561623942,0.596619656976076
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20719.Liking for sausages (meat),15511,-0.0101908003581966,0.0365765683479143,-0.0818808743201086,0.0614992736037153,0.780543604854539
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20720.Liking for savoury biscuits,15511,-0.0284083120548593,0.0370045060151764,-0.100937143844605,0.0441205197348864,0.442677897820741
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),15511,-0.0723614411185701,0.036462369801821,-0.143827685930139,-0.000895196307000828,0.0472120389308404
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20722.Liking for skimmed milk,15511,0.06596149430781,0.0366593467427225,-0.00589082530792609,0.137813813923546,0.0719892650458307
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20723.Liking for smoked fish,15511,0.00769326569633334,0.0368663466439908,-0.0645647737258886,0.0799513051185552,0.834700872878681
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20724.Liking for soft cheese,15511,-0.0389443157551942,0.0368696854059094,-0.111208899150777,0.0333202676403882,0.290861685872553
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20725.Liking for soy sauce,15511,-0.0443671795637342,0.0368019158446423,-0.116498934619233,0.0277645754917647,0.228002862490712
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20726.Liking for soya milk,15511,-0.0065306370269377,0.036802597382661,-0.0786637278969532,0.0656024538430778,0.859156912565174
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20727.Liking for spicy foods,15511,-0.0250050558465668,0.0367852471020767,-0.0971041401666371,0.0470940284735034,0.496668038595637
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20728.Liking for spinach,15511,-0.016503828260097,0.037073640314649,-0.0891681632768091,0.056160506756615,0.656207886168998
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20729.Liking for spirits,15511,-0.0806337794661166,0.0367205187540704,-0.152605996224095,-0.0086615627081386,0.0281154514347924
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20730.Liking for strawberries,15511,-0.0184463715259412,0.0398237221167377,-0.096500866874747,0.0596081238228646,0.643227102795256
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,15511,-0.00883078310272456,0.037690012749022,-0.0827032080908076,0.0650416418853585,0.814754912801333
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20732.Liking for sweet foods,15511,0.0279240430875038,0.0369777647754434,-0.0445523758723652,0.100400462047373,0.450165860408592
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20733.Liking for taking the stairs,15511,0.0228019087427936,0.037600869382457,-0.0508957952468221,0.0964996127324094,0.544244963738533
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20734.Liking for tea with sugar,15511,0.0243818441428076,0.0446632590912496,-0.0631581436760416,0.111921831961657,0.585139908897265
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20735.Liking for tea without sugar,15511,0.0440871225084787,0.0383155385679664,-0.0310113330847355,0.119185578101693,0.249901021401179
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20736.Liking for tomato ketchup,15511,-0.043954017645434,0.0365502421217153,-0.115592492203996,0.027684456913128,0.229163339750118
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20737.Liking for tinned tuna,15511,0.0252247767845835,0.0370394790760711,-0.0473726022045159,0.0978221557736828,0.495866441719004
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20738.Liking for turnip (white),15511,0.00916505689777217,0.0365530433839189,-0.0624789081347089,0.0808090219302532,0.802023814646541
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20739.Liking for vegetables,15511,0.0695742212034824,0.040265598153627,-0.00934635117762644,0.148494793584591,0.0840292310797814
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20740.Liking for vinegar,15511,0.0322519681164924,0.0366708537446534,-0.0396229052230282,0.104126841456013,0.37914458411048
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20741.Liking for watching television,15511,-0.0792522251647932,0.0370828206487699,-0.151934553636382,-0.00656989669320414,0.0325999299525989
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20742.Liking for whisky,15511,-0.0672721204311828,0.0381918835522885,-0.142128212193668,0.00758397133130259,0.0781863048501104
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20743.Liking for white bread,15511,0.0415745404705414,0.0366808889499731,-0.0303200018714058,0.113469082812489,0.25705904116313
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20744.Liking for white rice,15511,-0.0174696198798614,0.0369012840023115,-0.089796136524392,0.0548568967646692,0.635923831412164
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20745.Liking for white wine,15511,0.00432284955867625,0.0365372750624781,-0.0672902095637809,0.0759359086811334,0.905820867692801
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,15511,0.0145167744408173,0.0369855966081874,-0.0579749949112299,0.0870085437928646,0.6946956552187
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20747.Liking for whole milk,15511,0.0891307672317111,0.0364631414872369,0.0176630099167268,0.160598524546695,0.0145201094193789
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20748.Liking for wholemeal bread,15511,0.0312919234651112,0.0380512996788821,-0.0432886239054977,0.10587247083572,0.410883850568547
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20749.Liking for working up a sweat,15511,0.0317667581955642,0.0375513239444283,-0.0418338367355153,0.105367353126644,0.397590502510751
CCND2,G1/S-specific cyclin-D2,Physical measures,X21001.Body mass index (BMI),43753,0.013226401931376,0.00801490790973401,-0.00248281757170263,0.0289356214344547,0.0989040920696174
CCND2,G1/S-specific cyclin-D2,Physical measures,X21002.Weight,43786,-0.00404754625067231,0.00453367977570512,-0.0129335586110543,0.00483846610970973,0.371983732231031
CCND2,G1/S-specific cyclin-D2,Physical measures,X21021.Pulse wave Arterial Stiffness index,14773,-0.00154705464839239,0.00320178323091456,-0.00782254978098493,0.00472844048420015,0.628971326638814
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,14860,-0.00767468674551996,0.0401049209656114,-0.0862803318381183,0.0709309583470784,0.848242090182025
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,14877,-0.0718523018976718,0.0417821065547164,-0.153745230744916,0.0100406269495723,0.0855094939476362
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,14879,0.0247898579858532,0.0410681125199062,-0.0557036425531628,0.105283358524869,0.5461002803817
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21040.Satisfaction with bowel habits,14807,-0.0155803768802451,0.037969039433632,-0.0899996941701639,0.0588389404096737,0.681559385085805
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,14791,-0.00697492011509778,0.0406360836810173,-0.0866216441298916,0.0726718038996961,0.863720149244192
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21042.Greatest number of times bowels opened per day,14800,0.0357322154024725,0.0409163326416132,-0.0444637965750894,0.115928227380034,0.382514002054414
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21043.Least number of times bowels opened per week,14694,0.0911996467531254,0.0408346997145894,0.0111636353125303,0.171235658193721,0.0255385087667293
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21044.Average number of times bowels opened per day,14751,0.0845269826901014,0.0458060179631832,-0.00525281251773764,0.174306777897941,0.0650103587963229
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,14884,-0.017865639920045,0.0412813833929148,-0.0987771513701581,0.0630458715300681,0.665182943772251
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,14874,-0.00914884218534702,0.0415084053629176,-0.0905053166966655,0.0722076323259715,0.8255553634168
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,8377,-0.0437158984594624,0.0644344637958893,-0.170007447499405,0.0825756505804807,0.497501880358421
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,14880,0.0715232309678295,0.0450441273428355,-0.016763258624128,0.159809720559787,0.112341965383903
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,14877,0.012290658038798,0.062140627503842,-0.109504971868732,0.134086287946328,0.843213796384174
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,14877,0.058751788657957,0.0485251500177152,-0.0363575053767648,0.153861082692679,0.226010776802709
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,14875,0.129327918648517,0.118978961547191,-0.103870845983978,0.362526683281011,0.277062658969597
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,14884,-0.0232104774599376,0.0475262230222659,-0.116361874583579,0.0699409196637036,0.625293560033568
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,14880,-0.0542678032280335,0.0469786805564383,-0.146346017118653,0.0378104106625856,0.248044258654653
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,14525,0.0280663696357421,0.0430815184768759,-0.0563734065789346,0.112506145850419,0.514752664213602
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,14876,0.0156534752124854,0.0423762278359661,-0.0674039313460081,0.0987108817709789,0.711840195991587
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,14880,-0.0448691928175532,0.0619107966886461,-0.1662143543273,0.0764759686921932,0.468623334333169
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,14884,0.0300733946232212,0.0413849885868142,-0.0510411830069345,0.111187972253377,0.467437132404851
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,14883,0.000180543744162443,0.0412750771095804,-0.0807186073906152,0.0810796948789401,0.996509995994303
CCND2,G1/S-specific cyclin-D2,Working and living environment,X21100.Water hardness (USGS classification),43525,0.0269034112730619,0.0238394439036962,-0.0198218987781826,0.0736287213243064,0.259104437081485
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2139.Age first had sexual intercourse,37965,0.00253205357352,0.00208267047631737,-0.00154998056006205,0.00661408770710204,0.224079144753208
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2149.Lifetime number of sexual partners,35200,-0.0643329501403613,0.0267999816039948,-0.116860914084191,-0.0118049861965316,0.0163785281842513
CCND2,G1/S-specific cyclin-D2,Physical activities,X22032.IPAQ activity group,35165,0.0673140072949494,0.0262558613687702,0.0158525190121599,0.118775495577739,0.0103583127490466
CCND2,G1/S-specific cyclin-D2,Physical activities,X22033.Summed days activity,36094,0.0050093589747181,0.0020230405672595,0.00104419946288948,0.00897451848654673,0.0132851985698888
CCND2,G1/S-specific cyclin-D2,Physical activities,X22034.Summed minutes activity,35165,0.00454175097236639,0.00204022449623503,0.000542910959745727,0.00854059098498705,0.0260135614638805
CCND2,G1/S-specific cyclin-D2,Physical activities,X22037.MET minutes per week for walking,33662,0.00373470764943042,0.00208680984128844,-0.00035543963949492,0.00782485493835575,0.0735154525731414
CCND2,G1/S-specific cyclin-D2,Physical activities,X22038.MET minutes per week for moderate activity,35165,0.00625128068602857,0.00204310536492527,0.00224679417077503,0.0102557672012821,0.00221728814267265
CCND2,G1/S-specific cyclin-D2,Physical activities,X22039.MET minutes per week for vigorous activity,35165,0.0329306648090464,0.0261965418530468,-0.0184145572229253,0.0842758868410181,0.208739711070752
CCND2,G1/S-specific cyclin-D2,Physical activities,X22040.Summed MET minutes per week for all activity,33662,0.00576203549544224,0.00209286840385983,0.00166001342387696,0.00986405756700751,0.0059051766622328
CCND2,G1/S-specific cyclin-D2,Eye measures,X2217.Age started wearing glasses or contact lenses,37347,-0.00273010866992717,0.00201206062302687,-0.00667374749105983,0.00121353015120549,0.174830097075732
CCND2,G1/S-specific cyclin-D2,Working and living environment,X22501.Year ended full time education,10401,0.0136483566961266,0.00936521520299462,-0.00470746510174284,0.0320041784939961,0.145051190899192
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X22506.Tobacco smoking,10336,-0.0371281924294279,0.0982257477645948,-0.229650658048034,0.155394273189178,0.705446991436914
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,41100,0.0794904033595204,0.0631752459660592,-0.0443330787339557,0.203313885452996,0.208307648824054
CCND2,G1/S-specific cyclin-D2,Physical measures,X23098.Weight,43043,-0.00279362692055344,0.00457375983735492,-0.0117581962017691,0.00617094236066221,0.541338923824653
CCND2,G1/S-specific cyclin-D2,Physical measures,X23099.Body fat percentage,43013,-0.0250376143968794,0.00439231991932198,-0.0336465614387505,-0.0164286673550083,1.2036596357679e-08
CCND2,G1/S-specific cyclin-D2,Physical measures,X23100.Whole body fat mass,42969,-0.0166699190756809,0.00424329006774778,-0.0249867676084665,-0.00835307054289525,8.55980310107087e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23101.Whole body fat-free mass,43039,0.011635303600585,0.00382298187728143,0.00414225912111341,0.0191283480800566,0.00233972672300675
CCND2,G1/S-specific cyclin-D2,Physical measures,X23102.Whole body water mass,43043,0.0120891128639419,0.00382836601432747,0.00458551547586004,0.0195927102520237,0.00159088801260966
CCND2,G1/S-specific cyclin-D2,Physical measures,X23104.Body mass index (BMI),43043,0.0149229673356922,0.00805295061897418,-0.000860815877497175,0.0307067505488816,0.0638740753857422
CCND2,G1/S-specific cyclin-D2,Physical measures,X23105.Basal metabolic rate,43041,0.00926832913811739,0.00408910266849602,0.0012536879078652,0.0172829703683696,0.0234200775257497
CCND2,G1/S-specific cyclin-D2,Physical measures,X23106.Impedance of whole body,43037,-0.0200461865305262,0.00312632170169756,-0.0261737770658534,-0.013918595995199,1.45043749521298e-10
CCND2,G1/S-specific cyclin-D2,Physical measures,X23107.Impedance of leg (right),43040,-0.0184055687152771,0.00255895974142644,-0.023421129808473,-0.0133900076220813,6.46038709669806e-13
CCND2,G1/S-specific cyclin-D2,Physical measures,X23108.Impedance of leg (left),43039,-0.0162893806974062,0.00253774042299204,-0.0212633519264706,-0.0113154094683419,1.38731535152145e-10
CCND2,G1/S-specific cyclin-D2,Physical measures,X23109.Impedance of arm (right),43032,-0.0160025740449767,0.00311941936358508,-0.0221166359976034,-0.00988851209234991,2.91021346305592e-07
CCND2,G1/S-specific cyclin-D2,Physical measures,X23110.Impedance of arm (left),43038,-0.0156385772935759,0.0031205430926698,-0.0217548417552087,-0.00952231283194312,5.42234030778909e-07
CCND2,G1/S-specific cyclin-D2,Physical measures,X23111.Leg fat percentage (right),43039,-0.0333468877870763,0.0053158252121458,-0.043765905202882,-0.0229278703712705,3.57208408316022e-10
CCND2,G1/S-specific cyclin-D2,Physical measures,X23112.Leg fat mass (right),43038,-0.026912132018578,0.00564440255635454,-0.0379751610290329,-0.0158491030081231,1.86733939086633e-06
CCND2,G1/S-specific cyclin-D2,Physical measures,X23113.Leg fat-free mass (right),43037,0.0153980950890705,0.00400285689417088,0.00755249557649558,0.0232436946016454,0.000119854650077772
CCND2,G1/S-specific cyclin-D2,Physical measures,X23114.Leg predicted mass (right),43036,0.0150340027789061,0.00402375358315907,0.0071474457559143,0.0229205598018978,0.000186979408055607
CCND2,G1/S-specific cyclin-D2,Physical measures,X23115.Leg fat percentage (left),43033,-0.0296614374035214,0.00553460130393462,-0.0405092559592333,-0.0188136188478096,8.39866764145059e-08
CCND2,G1/S-specific cyclin-D2,Physical measures,X23116.Leg fat mass (left),43033,-0.0197510911315367,0.00588602136185542,-0.0312876930007733,-0.00821448926230007,0.00079263542511024
CCND2,G1/S-specific cyclin-D2,Physical measures,X23117.Leg fat-free mass (left),43030,0.0125968804334333,0.00417550195123967,0.00441289660900352,0.020780864257863,0.00255561909557474
CCND2,G1/S-specific cyclin-D2,Physical measures,X23118.Leg predicted mass (left),43029,0.0125505033544134,0.00419729622567859,0.00432380275208334,0.0207772039567434,0.00279007346238689
CCND2,G1/S-specific cyclin-D2,Physical measures,X23119.Arm fat percentage (right),43029,-0.019224389576523,0.00487114319777078,-0.0287718302441537,-0.00967694890889225,7.93990761238146e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23120.Arm fat mass (right),43026,-0.0102443022237748,0.00482511357977412,-0.0197015248401321,-0.000787079607417508,0.0337493685357191
CCND2,G1/S-specific cyclin-D2,Physical measures,X23121.Arm fat-free mass (right),43026,0.0112230727950715,0.003852515380209,0.00367214264986188,0.0187740029402811,0.0035795177219082
CCND2,G1/S-specific cyclin-D2,Physical measures,X23122.Arm predicted mass (right),43025,0.0134503855043621,0.00385656434891999,0.00589151938047894,0.0210092516282453,0.000487753577291449
CCND2,G1/S-specific cyclin-D2,Physical measures,X23123.Arm fat percentage (left),43021,-0.0195264593706571,0.00499551106169458,-0.0293176610515785,-0.00973525768973573,9.28973422838981e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23124.Arm fat mass (left),43021,-0.00940079514388849,0.00481118102048713,-0.0188307099440433,2.91196562662733e-05,0.0507138983009702
CCND2,G1/S-specific cyclin-D2,Physical measures,X23125.Arm fat-free mass (left),43017,0.0107620163118222,0.00392621598815433,0.00306663297503969,0.0184573996486047,0.0061265533350109
CCND2,G1/S-specific cyclin-D2,Physical measures,X23126.Arm predicted mass (left),43014,0.0113078867985253,0.00394048906766228,0.0035845282259072,0.0190312453711433,0.00411106045136065
CCND2,G1/S-specific cyclin-D2,Physical measures,X23127.Trunk fat percentage,43012,-0.0149363487163859,0.00314412870965487,-0.0210988409873094,-0.00877385644546231,2.03515460424695e-06
CCND2,G1/S-specific cyclin-D2,Physical measures,X23128.Trunk fat mass,43008,-0.0139594853333986,0.00346431032970883,-0.0207495335796279,-0.00716943708716929,5.59884807430814e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23129.Trunk fat-free mass,43003,0.00837755273377264,0.0034663701139949,0.00158346731034264,0.0151716381572026,0.015661388054703
CCND2,G1/S-specific cyclin-D2,Physical measures,X23130.Trunk predicted mass,42998,0.00804610366416655,0.00347085988306708,0.00124321829335508,0.014848989034978,0.020443807018058
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23400.Total Cholesterol,24445,0.0189271404990797,0.00252944701965986,0.0139694243405464,0.023884856657613,7.52556610374508e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,24445,0.0169603174983681,0.00244695147327732,0.0121642926107446,0.0217563423859917,4.27651832345396e-12
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",24445,0.0187841447068893,0.00244992771062841,0.0139822863940577,0.023586003019721,1.82292152321588e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23403.VLDL Cholesterol,24445,0.0156176687233014,0.00245084021269115,0.0108140219064267,0.0204213155401761,1.89444483887248e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23404.Clinical LDL Cholesterol,24445,0.0152046248674595,0.00244976232384607,0.0104030907127213,0.0200061590221978,5.50235679409341e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23405.LDL Cholesterol,24445,0.0146335143778648,0.00244258964686426,0.00984603867001085,0.0194209900857187,2.11494150389823e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23406.HDL Cholesterol,24445,0.0106940313547209,0.00285500412784981,0.00509822326413525,0.0162898394453065,0.000180293986419213
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23407.Total Triglycerides,24445,0.00844738765310687,0.00259604573431278,0.00335913801385382,0.0135356372923599,0.00113969330379577
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23408.Triglycerides in VLDL,24445,0.00755075089965884,0.00261451993242088,0.00242629183211391,0.0126752099672038,0.0038803200847757
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23409.Triglycerides in LDL,24445,0.0114035242259274,0.00252101136431076,0.00646234195187833,0.0163447064999765,6.11424634099328e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23410.Triglycerides in HDL,24445,0.00828880547233459,0.00250355030133501,0.00338184688171797,0.0131957640629512,0.000931576504488948
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,24445,0.0197932425679171,0.00256816713163719,0.0147596349899082,0.0248268501459259,1.335445076414e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23412.Phospholipids in VLDL,24445,0.0131899899229843,0.00250758955257758,0.0082751143999322,0.0181048654460363,1.45246760826801e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23413.Phospholipids in LDL,24445,0.0146659031689764,0.00243713491776729,0.00988911873015248,0.0194426876078003,1.79451429754458e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23414.Phospholipids in HDL,24445,0.011170188461041,0.00274552167880146,0.00578896597059013,0.0165514109514918,4.74628140175937e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23415.Total Esterified Cholesterol,24445,0.0186249822936257,0.00254309907658992,0.0136405081035094,0.0236094564837419,2.48628542244321e-13
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,24445,0.016347862273968,0.00243723676179612,0.0115708782208476,0.0211248463270884,2.02254874429248e-11
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,24445,0.0145379687479982,0.0024373111418885,0.00976083890989676,0.0193150985860997,2.48367902731226e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,24445,0.00912815902680805,0.00284471828383603,0.00355251119048943,0.0147038068631267,0.00133457779566115
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23419.Total Free Cholesterol,24445,0.0192849089666374,0.00249715994189496,0.0143904754805232,0.0241793424527515,1.18214725487951e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23420.Free Cholesterol in VLDL,24445,0.0142492020404422,0.00248346903109096,0.00938160273950394,0.0191168013413805,9.7150497511428e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23421.Free Cholesterol in LDL,24445,0.014401308038776,0.00246720317751599,0.00956558981084463,0.0192370262667073,5.37888754852208e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23422.Free Cholesterol in HDL,24445,0.0151122119724499,0.00285159254038738,0.00952309059329065,0.0207013333516092,1.17082545220979e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,24445,0.0186264076515058,0.00247626121697105,0.0137729356662426,0.0234798796367691,5.58072431205892e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23424.Total Lipids in VLDL,24445,0.0117806823204664,0.00253965492675435,0.0068029586640279,0.0167584059769049,3.52434181617894e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23425.Total Lipids in LDL,24445,0.0148882555435772,0.00243931825367857,0.0101071917663672,0.0196693193207872,1.05365837294733e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23426.Total Lipids in HDL,24445,0.0117570537129958,0.00278727777885286,0.00629398926644424,0.0172201181595474,2.47242147413676e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,24445,0.011616589653696,0.00261790336667516,0.00648549905501274,0.0167476802523794,9.1465296917849e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23428.Concentration of VLDL Particles,24445,0.0146535895160672,0.00247150211630674,0.00980944536810603,0.0194977336640285,3.08838658319742e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23429.Concentration of LDL Particles,24445,0.0154769501853449,0.00242962566343517,0.010714883885012,0.0202390164856778,1.92273394870433e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23430.Concentration of HDL Particles,24445,0.0091631737302388,0.00262599713514606,0.00401621934535252,0.0143101281151251,0.000484945406217913
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,24445,0.00131080679357131,0.00271577262307602,-0.00401210754765769,0.00663372113480031,0.62933836126817
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23432.Average Diameter for LDL Particles,24445,0.0038111113154676,0.00254381853493491,-0.00117477301300482,0.00879699564394002,0.134098056032694
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23433.Average Diameter for HDL Particles,24445,0.0111912937402286,0.00290616967219349,0.00549520118272932,0.0168873862977278,0.000117997023198756
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23434.Phosphoglycerides,24422,0.0173004001347912,0.00258549250650776,0.012232834822036,0.0223679654475464,2.25928660892401e-11
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,24422,0.00111981627253728,0.00275961527679267,-0.00428902966997635,0.00652866221505091,0.68490259698675
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23436.Total Cholines,24422,0.0182454536873797,0.00260965320719329,0.0131305334012808,0.0233603739734785,2.78919756960708e-12
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23437.Phosphatidylcholines,24422,0.0174662828001833,0.00261898071402184,0.0123330806007005,0.0225994849996662,2.62849094299158e-11
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23438.Sphingomyelins,24421,0.0179033247042858,0.00262763662223508,0.0127531569247051,0.0230534924838666,9.74873909974071e-12
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23439.Apolipoprotein B,24445,0.016459200461004,0.0024332353393568,0.0116900591958646,0.0212283417261433,1.36953392601616e-11
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23440.Apolipoprotein A1,24445,0.0103177879714853,0.00271293198183968,0.00500044128707948,0.015635134655891,0.000143193837027974
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,24445,0.00979707353343924,0.0024795918938876,0.00493707342141955,0.0146570736454589,7.80168812974714e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23442.Total Fatty Acids,24422,0.0154730130131792,0.00248237785202377,0.0106075524232126,0.0203384736031458,4.64653211855751e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23443.Degree of Unsaturation,24422,-0.00229797624189726,0.00266922243216728,-0.00752965220894513,0.00293369972515062,0.38929277738535
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23444.Omega-3 Fatty Acids,24422,0.00479891622148406,0.00252422408277748,-0.000148562980759808,0.00974639542372793,0.05729477705004
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23445.Omega-6 Fatty Acids,24422,0.0173286739857938,0.00248489961561558,0.0124582707391873,0.0221990772324003,3.16828494174348e-12
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,24422,0.0162044530874568,0.00249891601999569,0.0113065776882652,0.0211023284866483,9.06730643564391e-11
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,24422,0.0126910883187456,0.0025411222948143,0.00771048862090955,0.0176716880165816,5.94613735185072e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23448.Saturated Fatty Acids,24422,0.0154295715849687,0.00249467427232586,0.0105400100112101,0.0203191331587274,6.30863886754914e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23449.Linoleic Acid,24422,0.0179854094560005,0.00247385990248091,0.0131366440471379,0.0228341748648631,3.698083918933e-13
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23450.Docosahexaenoic Acid,24422,0.00310130340500355,0.0025954696417749,-0.00198581709287526,0.00818842390288236,0.232141216519194
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,24422,-0.00333858332975757,0.00253746883146681,-0.00831202223943251,0.00163485557991738,0.188282402770617
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,24422,-0.00493892033159212,0.0026537215442225,-0.0101402145582682,0.000262373895083993,0.0627378580487392
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,24422,-0.00623098784307181,0.00269890515719017,-0.0115208419511645,-0.000941133734979083,0.0209680220651446
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,24422,0.00276294340236621,0.00275246925553757,-0.00263189633848743,0.00815778314321984,0.315482389650666
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,24422,0.00663637676529465,0.00248783100044671,0.00176022800441909,0.0115125255261702,0.00764603141127399
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,24422,0.00570309032529406,0.00264580757248566,0.000517307483222166,0.010888873167366,0.0311309336758212
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,24422,-0.00684479817972318,0.00259919897540882,-0.0119392281715245,-0.00175036818792188,0.00845815319384041
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,24422,-0.00437165554905155,0.00275004793899429,-0.00976174950948035,0.00101843841137726,0.111923239971955
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,24420,0.00207405190987719,0.00251360754913779,-0.00285261888643288,0.00700072270618725,0.409306099519354
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23460.Alanine,24436,-0.00652716990433015,0.0024818326307939,-0.0113915618606862,-0.00166277794797411,0.0085443461854445
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23461.Glutamine,24366,-0.000985026980257404,0.00246199462464586,-0.00581053644456329,0.00384048248404848,0.689091479854661
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23462.Glycine,24415,0.0010295179836346,0.00259200028832196,-0.00405080258147645,0.00610983854874565,0.691230434668197
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23463.Histidine,24412,0.00134344728746165,0.00244395530463598,-0.00344670510962487,0.00613359968454816,0.58252876910252
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),24426,-0.000541326389789206,0.00259226198756985,-0.00562215988542612,0.00453950710584771,0.834587415762092
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23465.Isoleucine,24440,0.00107753103967432,0.00252716900173265,-0.00387572020372167,0.00603078228307031,0.669835675229897
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23466.Leucine,24441,-0.00134851397114794,0.0025812432903758,-0.00640775082028451,0.00371072287798863,0.601377048392908
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23467.Valine,24426,-0.000300357079655064,0.00259941697860752,-0.00539521435772581,0.00479450019841568,0.908011834859413
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23468.Phenylalanine,24434,0.00472303224304656,0.00246581129333919,-0.000109957891898257,0.00955602237799137,0.0554522839607958
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23469.Tyrosine,24414,0.00421505935773313,0.00251673717848179,-0.000717745512091167,0.00914786422755743,0.0939841155034789
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23470.Glucose,24400,0.00285855050075739,0.00249412754370916,-0.00202993948491257,0.00774704048642736,0.251759894432039
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23471.Lactate,24400,-0.00419845884499921,0.00247673797411064,-0.00905286527425607,0.000655947584257644,0.0900584747131016
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23472.Pyruvate,24365,-0.00391163065921949,0.00245435857063314,-0.00872217345766045,0.000898912139221472,0.11100532145067
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23473.Citrate,24441,0.00818134435587249,0.00248640880676242,0.00330798309461814,0.0130547056171268,0.00100177457326801
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23474.3-Hydroxybutyrate,24056,-0.00309232010755213,0.00251492407137492,-0.00802157128744697,0.00183693107234271,0.218863510974285
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23475.Acetate,24423,0.00761354043097694,0.00244696381362902,0.00281749135626406,0.0124095895056898,0.00186402488242779
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23476.Acetoacetate,24443,0.00317223327887157,0.00246184468055916,-0.00165298229502439,0.00799744885276752,0.197563484241917
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23477.Acetone,24443,-0.00262048437449725,0.00245917197097346,-0.00744046143760524,0.00219949268861073,0.286616736921849
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23478.Creatinine,23845,0.0155128659354339,0.00299044072013847,0.0096516021239625,0.0213741297469053,2.14896955817222e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23479.Albumin,24441,0.006856515152614,0.0024837042426972,0.0019884548369275,0.0117245754683005,0.00577382361845568
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23480.Glycoprotein Acetyls,24445,0.00684579531324443,0.00261977846149491,0.00171102952871441,0.0119805610977745,0.00897747738200342
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,24445,0.00752015197308751,0.00262830171622695,0.0023686806092827,0.0126716233368923,0.00422370939144386
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,24445,0.00757117765175943,0.00262036780923557,0.00243525674565771,0.0127070985578611,0.00386370161978934
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,24445,0.00611486113442593,0.00263982556744696,0.000940803022229894,0.011288919246622,0.0205453070078189
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,24445,0.00753231324255106,0.00261374603867197,0.002409371006754,0.0126552554783481,0.00395745448477892
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,24445,0.00830691534195653,0.00259894366856351,0.00321298575157206,0.013400844932341,0.00139395774355225
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,24445,0.00712832398060693,0.00261699709298377,0.00199900967835874,0.0122576382828551,0.00645704309165755
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,24445,0.00816902587897062,0.00260815608916399,0.00305703994420919,0.013281011813732,0.0017376105857693
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,24445,0.00753960989559882,0.00263420822718815,0.00237656177031005,0.0127026580208876,0.00421079337049635
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,24445,0.00754116467343973,0.00263068751076929,0.00238501715233191,0.0126973121945475,0.00415243684017312
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,24445,0.0087288226859732,0.00261643966087483,0.00360060095065853,0.0138570444212879,0.000850753699615191
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,24445,0.0102971893183137,0.0025612696890124,0.00527710072784941,0.015317277908778,5.82871979793553e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,24445,0.0108283118598982,0.00252560570067618,0.00587812468657294,0.0157784990332236,1.81459676976374e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,24445,0.00955473727066972,0.00259519106128078,0.00446816279055939,0.01464131175078,0.00023217486544819
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,24445,0.00595761044426347,0.00265543745564235,0.000752953031204464,0.0111622678573225,0.0248702004449649
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,24445,0.00820286153959088,0.00260151188120936,0.00310389825242054,0.0133018248267612,0.00161734577787674
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23496.Total Lipids in Large VLDL,24445,0.00798508678967932,0.00259516958463316,0.00289855440379834,0.0130716191755603,0.00209394211963708
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23497.Phospholipids in Large VLDL,24445,0.00757292687339751,0.00261049922543553,0.00245634839154387,0.0126895053552511,0.00372365531219616
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23498.Cholesterol in Large VLDL,24445,0.0103390182937303,0.00254703167889819,0.00534683620308981,0.0153312003843707,4.93854630295377e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,24445,0.0117275737348928,0.00250075395713803,0.00682609597890225,0.0166290514908833,2.75198318992363e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,24445,0.00865892166283175,0.00259786311743234,0.00356710995266436,0.0137507333729991,0.000860135143137433
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23501.Triglycerides in Large VLDL,24445,0.00659961766093074,0.00260405619137524,0.00149566752583527,0.0117035677960262,0.0112714609395033
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,24445,0.0145936549386293,0.00244840910811086,0.00979477308673203,0.0193925367905266,2.54971879971224e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,24445,0.0131585394922316,0.00246857955355195,0.00832012356726978,0.0179969554171934,9.88605421507545e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,24445,0.0148739679062716,0.00244343692009079,0.0100848315428936,0.0196631042696495,1.16530959227752e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,24445,0.016032720282362,0.00243834821607289,0.0112535577788592,0.0208118827858649,4.95556328911382e-11
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,24445,0.0157468154648614,0.002463661154117,0.0109180396027921,0.0205755913269308,1.67086482433345e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,24445,0.0155247348489578,0.0024340383003692,0.0107540197802342,0.0202954499176814,1.82411986768195e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,24445,0.00827363658218097,0.00255917635188897,0.00325765093247858,0.0132896222318834,0.00122690372069121
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,24445,0.011083659236088,0.00250009013122716,0.00618348257888274,0.0159838358932932,9.32040767337404e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23510.Total Lipids in Small VLDL,24445,0.0118806132234848,0.00249111210693981,0.00699803349388273,0.0167631929530868,1.86024743228467e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23511.Phospholipids in Small VLDL,24445,0.0137729283024418,0.00244947614762499,0.00897195505309685,0.0185739015517868,1.89931897457636e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23512.Cholesterol in Small VLDL,24445,0.0139038465201886,0.00244227505911032,0.00911698740433242,0.0186907056360449,1.26264481285838e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,24445,0.0132934613627137,0.00245224907082189,0.00848705318390277,0.0180998695415246,5.98523406562612e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,24445,0.0147218363332359,0.00243266574599425,0.00995381147108716,0.0194898611953846,1.45384472006588e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23515.Triglycerides in Small VLDL,24445,0.0063669338401055,0.00256908998265054,0.00133151747411045,0.0114023502061005,0.0132083153973167
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,24445,0.0188104743076522,0.00246733467618293,0.0139744983423336,0.0236464502729707,2.55258900331459e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,24445,0.0188921233892202,0.00247505864026862,0.0140410084542937,0.0237432383241467,2.37726815349202e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,24445,0.0176977424490859,0.00247043823442797,0.012855683509607,0.0225398013885647,8.06912977850464e-13
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,24445,0.0208577121798691,0.00250743878290069,0.0159431321653837,0.0257722921943544,9.38112595287856e-17
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,24445,0.0212645089348807,0.00252765476632659,0.0163103055928806,0.0262187122768808,4.22163109438098e-17
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,24445,0.0191240083370428,0.00247420260333604,0.0142745712345041,0.0239734454395814,1.12236644939259e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,24445,0.00900767516409291,0.00253088072463103,0.0040471489438161,0.0139682013843697,0.000372823610568317
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23523.Concentration of IDL Particles,24445,0.0186325827995478,0.00246469804589519,0.0138017746295932,0.0234633909695024,4.17926336420554e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23524.Total Lipids in IDL,24445,0.0200599388875373,0.00253079313044663,0.0150995843518619,0.0250202934232127,2.35276615781215e-15
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23525.Phospholipids in IDL,24445,0.0199697197611523,0.00253207996498023,0.0150068430297911,0.0249325964925136,3.2323448425293e-15
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23526.Cholesterol in IDL,24445,0.0194627521948698,0.00254207507069464,0.0144802850563083,0.0244452193334313,1.98522818401039e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,24445,0.0191907248460154,0.00254251274726202,0.0142073998613819,0.024174049830649,4.57647137604262e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23528.Free Cholesterol in IDL,24445,0.0196026301546947,0.00253587541583963,0.014632314339649,0.0245729459697403,1.11569179250053e-14
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23529.Triglycerides in IDL,24445,0.0119610438928636,0.0025096949276302,0.00704204183470836,0.0168800459510188,1.89060331906849e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23530.Concentration of Large LDL Particles,24445,0.0155788281508792,0.00243552016464204,0.0108052086281808,0.0203524476735776,1.61846390388304e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23531.Total Lipids in Large LDL,24445,0.0156236425017765,0.00245899686620719,0.0108040086440104,0.0204432763595426,2.13950605645611e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23532.Phospholipids in Large LDL,24445,0.0155850869581338,0.0024552699352164,0.0107727578851097,0.0203974160311579,2.2253153821411e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23533.Cholesterol in Large LDL,24445,0.0152332362777266,0.0024651538421758,0.010401534747062,0.0200649378083912,6.53515642919828e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,24445,0.0149081583938791,0.00245644610281451,0.0100935240323627,0.0197227927553956,1.30608132932505e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,24445,0.0157499927535005,0.00249364760995063,0.0108624434379973,0.0206375420690038,2.72961435100418e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23536.Triglycerides in Large LDL,24445,0.011972560705418,0.00251095841790213,0.00705108220632984,0.0168940392045062,1.87020533702851e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,24445,0.014073325836836,0.00242986176531267,0.00931079677682317,0.0188358548968488,7.0480479533563e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23538.Total Lipids in Medium LDL,24445,0.0130876832584894,0.00243060402341561,0.00832369937259479,0.017851667144384,7.33001959596184e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23539.Phospholipids in Medium LDL,24445,0.0126275023766101,0.00242809496471881,0.00786843624576127,0.017386568507459,2.00268200320286e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23540.Cholesterol in Medium LDL,24445,0.0129915562734795,0.00242875219158021,0.00823120197798227,0.0177519105689767,8.92038469472817e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,24445,0.0130431330940169,0.00243514570103159,0.00827024751999498,0.0178160186680388,8.57572117102092e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,24445,0.0120935355900395,0.00243443595129664,0.0073220411254981,0.0168650300545809,6.82105354884562e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23543.Triglycerides in Medium LDL,24445,0.0102005376489293,0.00253435693040969,0.00523319806532634,0.0151678772325323,5.7170872738651e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23544.Concentration of Small LDL Particles,24445,0.0152838695209821,0.00242816442608566,0.0105246672458542,0.02004307179611,3.13807912861086e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23545.Total Lipids in Small LDL,24445,0.0141301436691158,0.00242902646889059,0.00936925179009024,0.0188910355481413,6.05860167728915e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23546.Phospholipids in Small LDL,24445,0.0137194931031676,0.00242988066217293,0.00895692700530869,0.0184820592010266,1.65892345389556e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23547.Cholesterol in Small LDL,24445,0.0138431036945126,0.00242639231177637,0.00908737476343093,0.0185988326255943,1.17535099811938e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,24445,0.014376414955424,0.00243170967414616,0.00961026399409752,0.0191425659167505,3.42342009906267e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,24445,0.0112599859287934,0.00243387115294346,0.00648959846902418,0.0160303733885626,3.74040629222791e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23550.Triglycerides in Small LDL,24445,0.00994176562128787,0.00255987950396133,0.00492440179352366,0.0149591294490521,0.000103156024874673
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,24445,0.0179328882986023,0.00285859646915928,0.0123300392190501,0.0235357373781545,3.59357049569327e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,24445,0.0161239386678871,0.00286896086303192,0.0105007753763445,0.0217471019594297,1.9289093380663e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,24445,0.0150134051942446,0.0028584207634517,0.00941090049787922,0.0206159098906099,1.51434217663832e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,24445,0.0157875115038543,0.00287927934334439,0.0101441239908993,0.0214308990168093,4.21961270880163e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,24445,0.0156231795643379,0.00291306383366034,0.00991357445036366,0.0213327846783122,8.25286182016387e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,24445,0.0155683509488107,0.00272699594893291,0.0102234388889022,0.0209132630087192,1.14975544794352e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,24445,0.0131784968968006,0.00247076606039498,0.00833579541842648,0.0180211983751748,9.70496199503101e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23558.Concentration of Large HDL Particles,24445,0.0139257249901824,0.0029655261451506,0.00811329374568726,0.0197381562346776,2.6691629235608e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23559.Total Lipids in Large HDL,24445,0.0126362627942764,0.00294323162589778,0.00686752880751673,0.018404996781036,1.76691673058954e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23560.Phospholipids in Large HDL,24445,0.0114372575145476,0.00290749937819327,0.00573855873328881,0.0171359562958064,8.38760229870282e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23561.Cholesterol in Large HDL,24445,0.0125664784582874,0.00296656391899481,0.00675201317705755,0.0183809437395172,2.28330612261039e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,24445,0.0117992900768995,0.00296682462576814,0.005984313810394,0.0176142663434051,6.99685008375637e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,24445,0.0146937238563772,0.00294647111801427,0.00891864046506926,0.0204688072476852,6.17795908350187e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23564.Triglycerides in Large HDL,24445,0.0113779729251376,0.0025245433533682,0.00642986795253587,0.0163260778977392,6.60733811095034e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,24445,0.00810991991702662,0.00268586680593877,0.00284562097738663,0.0133742188566666,0.00253470756271711
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23566.Total Lipids in Medium HDL,24445,0.00781374426526358,0.00265126329268825,0.0026172682115946,0.0130102203189326,0.00320991801276043
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23567.Phospholipids in Medium HDL,24445,0.0080425383746651,0.00261938235497134,0.00290854895892127,0.0131765277904089,0.00214010464009173
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23568.Cholesterol in Medium HDL,24445,0.00627476772009152,0.00270642661774976,0.000970171549301983,0.0115793638908811,0.0204320273977326
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,24445,0.0052119556868163,0.00269642943947187,-7.30460145485718e-05,0.0104969573881812,0.0532588161264973
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,24445,0.0103683169353714,0.0027315536282666,0.00501447182396883,0.0157221620467739,0.000147548349009416
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23571.Triglycerides in Medium HDL,24445,0.00779284172341797,0.0025048729828575,0.00288329067701727,0.0127023927698187,0.00186623778031029
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23572.Concentration of Small HDL Particles,24445,0.00420824759884614,0.00243865414660896,-0.000571514528507426,0.0089880097261997,0.0844242188201458
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23573.Total Lipids in Small HDL,24445,0.00546215586290463,0.00245748301024646,0.000645489162821578,0.0102788225629877,0.026247669314515
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23574.Phospholipids in Small HDL,24445,0.00592217909496902,0.00246965324956968,0.00108165872581244,0.0107626994641256,0.0164932209577844
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23575.Cholesterol in Small HDL,24445,0.00370263492525109,0.0024394077829746,-0.00107860432937913,0.00848387417988131,0.129067242030813
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,24445,0.00144810883217204,0.00242904023700056,-0.00331281003234906,0.00620902769669314,0.551070511647636
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,24445,0.0100219562485554,0.00248598594484577,0.00514942379665767,0.0148944887004531,5.56182142774934e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23578.Triglycerides in Small HDL,24445,0.00435960788888681,0.00262415645410033,-0.000783738761149833,0.00950295453892346,0.0966586383218765
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,-0.00904071375646902,0.0024965171396296,-0.013933887350143,-0.00414754016279501,0.000293711485750386
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,-0.00362733280767182,0.00252630864602109,-0.00857889775387316,0.00132423213852952,0.151066008201173
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,-0.00196564866955518,0.00250026528307716,-0.00686616862438641,0.00293487128527605,0.431772326702531
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,-0.00710714353280984,0.00255203144334773,-0.0121091251617714,-0.00210516190384829,0.00535878692744179
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,23393,0.00562360433432574,0.00248981987748655,0.000743557374452109,0.0105036512941994,0.0239150230718763
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,24185,0.011287451433907,0.00243268801642603,0.00651938292171197,0.016055519946102,3.50389627040172e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,24185,0.00407871262145109,0.00266665214355862,-0.00114792557992381,0.00930535082282599,0.126147292885692
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,24185,0.00258299872000591,0.00266374825916371,-0.00263794786795496,0.00780394530796677,0.332212859975488
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,24185,0.00947926343825375,0.00258085787042548,0.0044207820122198,0.0145377448642877,0.00024031936744044
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,24185,-0.00687747488093218,0.00260138024541185,-0.0119761801619394,-0.00177876959992495,0.00820390490706591
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,24440,0.00351152333335529,0.00258874842024781,-0.00156242357033042,0.00858547023704101,0.174966662283559
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,24440,0.00624629866554888,0.00250134109380839,0.00134367012168443,0.0111489272094133,0.0125250733426231
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,24440,0.00729118754697236,0.00259289778665014,0.00220910788513808,0.0123732672088066,0.00492761745171148
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,24440,0.00390261325189998,0.00244780905974196,-0.000895092505194253,0.00870031900899422,0.110875278075795
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,24440,-0.00591997824304446,0.00242302208401548,-0.0106691015277148,-0.00117085495837413,0.014563854050005
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,24445,0.0138014441416297,0.00256015735700498,0.00878353572189993,0.0188193525613594,7.07718144102369e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,24445,0.01007348,0.002674773,0.004830922,0.01531603,0.0001662026
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,24445,0.00898001453995451,0.00269415547148301,0.00369946981584781,0.0142605592640612,0.000859972947981037
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,24445,0.012680156406439,0.00261041631410005,0.00756374043080287,0.0177965723820751,1.19599018153563e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,24445,-0.0110678252346972,0.00265207536758446,-0.0162658929551627,-0.00586975751423163,3.01297639431696e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,24445,0.00940918008972806,0.00260804336930339,0.00429741508589342,0.0145209450935627,0.000309474765818668
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,24445,0.00893301625105095,0.00252736350739576,0.00397938377655525,0.0138866487255466,0.000409271718119138
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,24445,0.00746609625438607,0.00246581259950147,0.00263310355936319,0.0122990889494089,0.00246561911983294
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,24445,0.00983785086761749,0.00262308945880968,0.00469659552835051,0.0149791062068845,0.000176902019407746
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,24445,-0.00921355714168935,0.00255287104496369,-0.0142171843898182,-0.00420992989356051,0.000307879545375758
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,24445,-0.00659636532838937,0.00254976944699048,-0.0115939134444907,-0.00159881721228802,0.00968604976374282
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,24445,0.0124477340547691,0.00266203696336412,0.00723014160657547,0.0176653265029628,2.94061167007361e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,24445,0.0125558991588946,0.00268900312501477,0.00728545303386564,0.0178263452839235,3.03758571167403e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,24445,0.00832554569643663,0.00246530614229666,0.00349354565753518,0.0131575457353381,0.000733729281280254
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,24445,-0.0117555040394598,0.00264249658647698,-0.0169347973489547,-0.00657621072996493,8.67988960660178e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,24445,-0.00629994229884531,0.00243536347975081,-0.0110732547191569,-0.00152662987853371,0.00969124123569973
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,24445,0.00870656059883459,0.00256395126656366,0.00368121611636983,0.0137319050812994,0.00068547511387753
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,24445,0.00660205451125313,0.00255011146200244,0.00160383604572836,0.0116002729767779,0.00963323287460913
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,24445,0.00598375769858114,0.00248467226815178,0.00111380005300364,0.0108537153441586,0.0160357507788819
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,24445,-0.00820296063695313,0.00261443580001097,-0.0133272548049746,-0.00307866646893163,0.00170560259389507
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,24445,-0.00385388386298723,0.00244907034030482,-0.00865406172998468,0.000946294004010225,0.115590373065204
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,24445,0.00610377684524772,0.00260395685789045,0.00100002140378244,0.011207532286713,0.0190841365986232
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,24445,0.00155284465163521,0.00242870793704295,-0.00320742290496896,0.00631311220823939,0.522587811115261
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,24445,0.0077262171872658,0.00268534134456296,0.0024629481519224,0.0129894862226092,0.00401590873430792
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,24445,-0.00540010084932274,0.00257186027077822,-0.010440946980048,-0.000359254718597437,0.035766638528242
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,24445,-0.00721390513263182,0.00245289525479907,-0.012021579832038,-0.00240623043322565,0.00327487086752475
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,24445,0.00813817791824573,0.00247320170476516,0.00329070257690602,0.0129856532595854,0.00100135630591285
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,24445,0.00762397108889504,0.00249963194484238,0.00272469247700398,0.0125232497007861,0.00229057872230183
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,24445,-0.00139903557780571,0.00266535027019368,-0.00662312210738532,0.0038250509517739,0.599659240460112
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,24445,-0.00476095449936684,0.00251805005568801,-0.00969633260851534,0.000174423609781647,0.0586721262008765
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,24445,-0.00680124970081615,0.00246632738981545,-0.0116352513848544,-0.00196724801677786,0.00582630453400754
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,24445,0.00676011982813834,0.00245003029881628,0.00195806044245843,0.0115621792138183,0.0057986464266353
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,24445,0.00920307864447073,0.00246427111332504,0.00437310726235365,0.0140330500265878,0.000188437251766006
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,24445,-0.00278555140351649,0.00257385917392678,-0.00783031538441299,0.00225921257738,0.279153465045415
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,24445,-0.00158262125572809,0.00258195675000956,-0.00664325648574682,0.00347801397429064,0.539912323944508
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,24432,0.0085921493032154,0.00274396476308032,0.00321397836757797,0.0139703202388528,0.00174245603001454
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,24432,-0.00915326499962068,0.00256057046104178,-0.0141719831032626,-0.00413454689597879,0.000351309159304816
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,24432,-0.00239377040942002,0.00246532888072623,-0.00722581501564343,0.00243827419680339,0.331570810502521
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,24432,-0.0116897249315436,0.00289891315527623,-0.017371594715885,-0.00600785514720217,5.53657663086065e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,24432,-0.00214255814039332,0.00271962994536943,-0.0074730328333174,0.00318791655253075,0.430814105705044
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,24445,-0.0106254762668014,0.00270273624908176,-0.0159228393150016,-0.00532811321860113,8.46933935870604e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,24445,0.00589679568066979,0.00277775326037034,0.000452399290343917,0.0113411920709957,0.03377517780476
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,24445,0.00221546899068059,0.00273405788231517,-0.00314328445865714,0.00757422244001833,0.417762661596154
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,24445,0.0172088302444103,0.00267280162441564,0.0119701390605557,0.022447521428265,1.22902064210698e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,24445,-0.000488482846430383,0.00267990557038573,-0.00574109776438642,0.00476413207152566,0.855367533830525
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,24445,-0.000740988421240649,0.00273576406317084,-0.0061030859850555,0.0046211091425742,0.786506799714123
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,24445,-0.00233768793532238,0.00269161331946854,-0.00761325004148072,0.00293787417083596,0.385124778402878
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,24445,-0.00606433540922682,0.00261436189506694,-0.011188484723558,-0.000940186094895622,0.020369451741299
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,24445,0.0151192227565107,0.00286986435180839,0.00949428862696624,0.0207441568860551,1.38881537631356e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,24445,0.00426037417231318,0.00262856815513578,-0.000891619411752954,0.00941236775637931,0.105074186020848
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,24445,0.00279268485315204,0.00249292969692161,-0.00209345735281432,0.0076788270591184,0.262621610910754
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,24445,-0.00354502601485409,0.00250083737696697,-0.00844666727370936,0.00135661524400117,0.156339146252346
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,24445,-0.00711263819631144,0.00248228582528163,-0.0119779184138634,-0.00224735797875944,0.00416893036022809
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,24445,0.0140217150045401,0.00261583099271677,0.00889468625881517,0.0191487437502649,8.38232727411362e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,24445,0.00229577224984946,0.00267235206559472,-0.00294203779871618,0.0075335822984151,0.390303150283219
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,43318,0.00316906749414452,0.00209791146906675,-0.000942838985226311,0.00728097397351535,0.130902256118952
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,43318,0.00382308652757815,0.00205013608988072,-0.000195180208588074,0.00784135326374437,0.0622166985834721
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,40248,0.00536721870447835,0.00196343860598875,0.0015188790367404,0.00921555837221629,0.00626770696725242
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,40248,0.00318951004392958,0.00214312703520986,-0.00101101894508173,0.0073900390329409,0.136692661222328
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,40248,0.00106858706250967,0.00210339876317072,-0.00305407451330494,0.00519124863832427,0.611435960134468
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,40248,0.00445938346560717,0.00193545619644816,0.000665889320568784,0.00825287761064556,0.0212250337433642
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24009.Traffic intensity on the nearest road,43318,-0.0322727088744289,0.0516785279648328,-0.133562623685501,0.0690172059366433,0.532309316995826
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24010.Inverse distance to the nearest road,43318,-0.000910683733650245,0.0018389296651812,-0.0045149858774054,0.00269361841010491,0.620443898670105
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24011.Traffic intensity on the nearest major road,43318,0.00395100719625061,0.00183252507815765,0.000359258043061622,0.0075427563494396,0.0310856127897229
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24012.Inverse distance to the nearest major road,43318,0.000282240685530452,0.00187101341774301,-0.00338494561324586,0.00394942698430676,0.880095457774913
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24013.Total traffic load on major roads,43318,0.0193993132981126,0.03627010155297,-0.0516900857457086,0.0904887123419338,0.592751574728995
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24015.Sum of road length of major roads within 100m,43318,0.00102100045346204,0.0351713595451944,-0.067914864255119,0.0699568651620431,0.976841344722819
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,43318,0.00264789127199946,0.00209866992967778,-0.00146550179016899,0.00676128433416791,0.207063652014853
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,43318,0.00289506500117751,0.00209625897086544,-0.00121360258171875,0.00700373258407378,0.16726682037305
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,43318,0.00225743003745557,0.00207411564770971,-0.00180783663205546,0.0063226967069666,0.27643258243181
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,43221,0.00140754787127017,0.00203108987164255,-0.00257338827714923,0.00538848401968957,0.488312476032766
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24020.Average daytime sound level of noise pollution,43318,-0.000324907203273988,0.00184311014958029,-0.00393740309645136,0.00328758868990338,0.860073201312206
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24021.Average evening sound level of noise pollution,43318,-0.00028608024761271,0.00184324754109493,-0.00389884542815877,0.00332668493293335,0.876660852125625
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24022.Average night-time sound level of noise pollution,43318,-0.000330390291203678,0.00184310071616878,-0.00394286769489448,0.00328208711248712,0.857736071902627
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,43318,-0.000285764381862711,0.00184317477167933,-0.0038983869343542,0.00332685817062878,0.876791119353444
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,43318,-0.000297799691475887,0.00184324135937277,-0.00391055275584652,0.00331495337289475,0.871650712406079
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2405.Number of children fathered,19884,0.00613374685179536,0.0397364527536139,-0.071749700545288,0.0840171942488787,0.877326903037841
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",38382,-0.00173223405701545,0.00216735842521175,-0.00598025657043048,0.00251578845639959,0.424157678479022
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",38382,0.00204339650481104,0.00196317901256376,-0.00180443435981392,0.00589122736943601,0.297946614802005
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24502.Water percentage, buffer 1000m",38382,-0.00313306908429147,0.00194847531365078,-0.00695208069904699,0.000685942530464055,0.107852311640181
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",38382,-0.00216188408538734,0.00203652182821515,-0.00615346686868903,0.00182969869791435,0.28844350670241
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",38382,0.00186294852372777,0.00198309108670503,-0.0020239100062141,0.00574980705366963,0.347522849305749
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24505.Water percentage, buffer 300m",38382,-0.00274389937397715,0.00196092999371329,-0.0065873221616552,0.00109952341370089,0.161735704569356
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",43526,-0.00362523615024007,0.00206112664165336,-0.00766504436788066,0.000414572067400518,0.0786080760746324
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",43526,-0.00573181183886751,0.0019395778875732,-0.00953338449851098,-0.00193023917922404,0.00312648840679292
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24508.Distance (Euclidean) to coast,43526,3.20578012693077e-05,0.00183941240066567,-0.0035731905040354,0.00363730610657402,0.986095025310658
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,9639,-0.0366107754343914,0.0538455801409414,-0.142148112510636,0.0689265616418537,0.496570427689041
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2704.Years since last cervical smear test,18024,0.0597216816137192,0.0382063180023553,-0.0151627016708971,0.134606064898336,0.118038114825418
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2714.Age when periods started (menarche),22973,-0.00206469550384183,0.0324225103455187,-0.0656128157810585,0.0614834247733749,0.949224846611901
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2734.Number of live births,23702,-0.00337441039557854,0.0312062797745033,-0.0645387187536049,0.0577898979624478,0.913891571536937
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2744.Birth weight of first child,18859,-0.00885954159125561,0.0346897961292971,-0.0768515420046779,0.0591324588221666,0.798422131653869
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2754.Age at first live birth,16076,0.000680890877281034,0.00317425616156718,-0.00554065119939063,0.0069024329539527,0.830156713521357
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2764.Age at last live birth,16029,0.00234184387064788,0.00305746148933643,-0.00365078064845153,0.00833446838974728,0.443720991791378
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2794.Age started oral contraceptive pill,18137,-0.000708300924066738,0.00349926805880605,-0.00756686631932659,0.00615026447119311,0.839595338797122
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2804.Age when last used oral contraceptive pill,16454,0.000250932116372868,0.003055290906167,-0.00573743805971445,0.00623930229246019,0.934544057345571
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2867.Age started smoking in former smokers,10768,0.00457484102646466,0.0037806082249316,-0.00283515109440128,0.0119848331473306,0.226274527642756
CCND2,G1/S-specific cyclin-D2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",16334,0.0176429718310449,0.0455708317461848,-0.0716758583914773,0.106961802053567,0.698646568514393
CCND2,G1/S-specific cyclin-D2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,16326,0.00152305609585129,0.0503790196079704,-0.0972198223357707,0.100265934527473,0.975882436169833
CCND2,G1/S-specific cyclin-D2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,16356,0.0459010627466873,0.0525647177601942,-0.0571257840632933,0.148927909556668,0.38255082528078
CCND2,G1/S-specific cyclin-D2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",16308,0.0755818873921924,0.0512247913281356,-0.0248187036109533,0.175982478395338,0.140099025764946
CCND2,G1/S-specific cyclin-D2,Mental health,X28739.Difficulty with standing for long periods,16374,-0.0149005414256906,0.0441032016992262,-0.101342816756174,0.0715417339047928,0.735475869584522
CCND2,G1/S-specific cyclin-D2,Mental health,X28740.Difficulty with taking care of household responsibilities,16414,-0.00575500483142336,0.0492656521378651,-0.102315683021639,0.0908056733587922,0.90700748146544
CCND2,G1/S-specific cyclin-D2,Mental health,X28741.Difficulty learning a new task,16281,0.1189980644389,0.0566578531736705,0.00794867221850605,0.230047456659294,0.0357184770446702
CCND2,G1/S-specific cyclin-D2,Mental health,X28742.Difficulty with joining in community activities,15672,0.0582186838852996,0.0565794179976058,-0.0526769753900077,0.169114343160607,0.303508339560688
CCND2,G1/S-specific cyclin-D2,Mental health,X28743.Difficulty with being emotionally affected by health problems,16309,0.0534916380068261,0.0481319165076298,-0.0408469183481284,0.147830194361781,0.266432046224007
CCND2,G1/S-specific cyclin-D2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,16413,0.00632169354651687,0.0683339803307966,-0.127612907901845,0.140256294994878,0.926292616109855
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,10240,-0.0741592297938355,0.0513840798189819,-0.17487202623904,0.0265535666513689,0.14898531540919
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2897.Age stopped smoking,10764,0.00605231481782516,0.00395272401891439,-0.00169502425924705,0.0137996538948974,0.125755409219361
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,14613,0.0036860334659433,0.00684813488683499,-0.00973631091225328,0.0171083778441399,0.5904101648888
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,14613,-0.00452453527578185,0.00744105950668586,-0.0191090119088861,0.0100599413573224,0.543163856762737
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,14613,-0.0161115638715656,0.0249734461507034,-0.0650595183269442,0.0328363905838131,0.518841547489791
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,14613,-0.00388776281750242,0.0263292650656151,-0.055493122346108,0.0477175967111031,0.882613633481854
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,14613,-0.0258151902123598,0.0287869785762002,-0.0822376682217123,0.0306072877969927,0.369858459235004
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,14613,0.000812953226769425,0.0241302242763272,-0.0464822863548319,0.0481081928083707,0.973124616549364
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,14613,-0.0108275577620456,0.0107922768677171,-0.031980420422771,0.0103253048986798,0.315747675260566
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,14613,0.00984242440242088,0.0193219392562031,-0.0280285765397373,0.047713425344579,0.610485794212172
CCND2,G1/S-specific cyclin-D2,Mental health,X29002.Recent lack of interest or pleasure in doing things,14533,0.0608059583496964,0.0532686603367763,-0.0436006159103851,0.165212532609778,0.253682438273306
CCND2,G1/S-specific cyclin-D2,Mental health,X29003.Recent feelings of depression,14522,0.0908020086910713,0.051596314348529,-0.0103267674320454,0.191930784814188,0.0784535454758979
CCND2,G1/S-specific cyclin-D2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",14541,0.10265954512608,0.0412163518297994,0.0218754955396737,0.183443594712487,0.0127585315477979
CCND2,G1/S-specific cyclin-D2,Mental health,X29005.Recent feelings of tiredness or low energy,14551,0.0276058954559916,0.0414381626663815,-0.0536129033701161,0.108824694282099,0.505297061826409
CCND2,G1/S-specific cyclin-D2,Mental health,X29006.Recent poor appetite or overeating,14562,0.101907415883282,0.0587315657822884,-0.0132064530500033,0.217021284816567,0.0827374113943371
CCND2,G1/S-specific cyclin-D2,Mental health,X29007.Recent feelings of inadequacy,14501,0.0545458711538305,0.0562680333614597,-0.0557394742346306,0.164831216542292,0.332365032587425
CCND2,G1/S-specific cyclin-D2,Mental health,X29008.Recent trouble concentrating on things,14559,0.141978332601174,0.0561991600231247,0.0318279789558494,0.252128686246498,0.0115362232837783
CCND2,G1/S-specific cyclin-D2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,14543,0.213607596017246,0.0998400624759127,0.0179210735644566,0.409294118470035,0.0324119871445495
CCND2,G1/S-specific cyclin-D2,Mental health,X29010.Recent thoughts of suicide or self-harm,14469,0.0329545735178548,0.107991543403113,-0.178708851552248,0.244617998587957,0.760249577610671
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#0.Substances taken for depression_None of options listed,13751,0.0139119504350168,0.0132016632772621,-0.011963309588417,0.0397872104584506,0.291991721307239
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),13751,-0.00558691193816534,0.0252594623445005,-0.0550954581333862,0.0439216342570556,0.824954827179311
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),13751,0.016401460826898,0.01323920622108,-0.00954738336641877,0.0423503050202148,0.215420256629745
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),13751,-0.0192414763251839,0.0392398902368467,-0.0961516611894035,0.0576687085390357,0.623890546609443
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),13751,0.0268083547661549,0.024978091166584,-0.0221487039203498,0.0757654134526596,0.283166709938778
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),13751,0.00715134784576048,0.0266439867823269,-0.0450708662476002,0.0593735619391212,0.788392529367864
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),13751,-0.0290560027076549,0.0308471607967595,-0.0895164378693036,0.0314044324539938,0.346242777311284
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),13751,-0.0122464710794006,0.0344926004467565,-0.0798519679550435,0.0553590257962422,0.722560336363428
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),13751,0.0199241305258426,0.0253891465054324,-0.0298385966248048,0.06968685767649,0.432613744217592
CCND2,G1/S-specific cyclin-D2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,13751,0.00458263356518547,0.0129938303451686,-0.0208852739113451,0.030050541041716,0.724335526785944
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,13751,-0.0153412375011566,0.0201317934694886,-0.0547995527013542,0.024117077699041,0.446049048053804
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,13751,-0.0097578408558414,0.031746747322935,-0.071981465608794,0.0524657838971112,0.75857018022794
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,13751,0.0143468732821048,0.0402329915574312,-0.0645097901704604,0.0932035367346701,0.721400690478423
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,13751,0.00876549388539344,0.0262572057567772,-0.0426986293978899,0.0602296171686767,0.738511477190212
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,13751,0.00353620862716816,0.0415496681293495,-0.0779011409063568,0.0849735581606931,0.932176780677305
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,13751,-0.00550302420105484,0.0392439165647754,-0.0824211006680147,0.071415052265905,0.888483349687134
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,13751,-0.0195864458495278,0.0216611367581322,-0.062042273895467,0.0228693821964113,0.365894301344676
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,13751,-0.00666240288858118,0.0212585394476184,-0.0483291402059132,0.0350043344287509,0.753982377669172
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,13751,-0.020693600363698,0.0305225316550031,-0.080517762407504,0.039130561680108,0.497797157137433
CCND2,G1/S-specific cyclin-D2,Mental health,X29058.Recent feelings or nervousness or anxiety,14324,0.0326100192016894,0.0482600492965855,-0.0619796774196182,0.127199715822997,0.499232794454894
CCND2,G1/S-specific cyclin-D2,Mental health,X29059.Recent inability to stop or control worrying,14338,0.0367425031651811,0.0502140986903717,-0.0616771302679474,0.13516213659831,0.464353369146492
CCND2,G1/S-specific cyclin-D2,Mental health,X29060.Recent worrying too much about different things,14332,0.0660658137226253,0.0463652029963589,-0.0248099841502381,0.156941611595489,0.154207684746319
CCND2,G1/S-specific cyclin-D2,Mental health,X29061.Recent trouble relaxing,14334,0.0343240104375233,0.0491898811112576,-0.0620881565405415,0.130736177415588,0.485322365970005
CCND2,G1/S-specific cyclin-D2,Mental health,X29062.Recent restlessness,14350,0.0771175906041129,0.0706809058898348,-0.0614169849399634,0.215652166148189,0.27526182476376
CCND2,G1/S-specific cyclin-D2,Mental health,X29063.Recent easy annoyance or irritability,14307,0.0658648569104592,0.0501282288282481,-0.0323864715929071,0.164116185413825,0.188891703701362
CCND2,G1/S-specific cyclin-D2,Mental health,X29064.Recent feelings of foreboding,14304,0.121960971446036,0.0575069795099104,0.00924729160661196,0.234674651285461,0.0339555654362784
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,13751,0.00315302500852853,0.0140209522865743,-0.024328041473157,0.0306340914902141,0.822076347438829
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,13751,0.0384140684105001,0.0229553152432876,-0.00657834946634354,0.0834064862873438,0.0942658279735909
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',13751,0.0278000442722526,0.0300937181177352,-0.0311836432385084,0.0867837317830136,0.355615895928105
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,13751,0.0289523838179755,0.0318427633409053,-0.0334594323301988,0.0913641999661498,0.363244880426978
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#2.Symptoms of panic attack_Sweating,13751,-0.0257421524144865,0.021223361697766,-0.0673399413421078,0.0158556365131348,0.22518284092604
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,13751,0.0194167741445263,0.0227813629194533,-0.0252346971776023,0.0640682454666548,0.39405714225287
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,13751,0.00694312657859075,0.0227442701837204,-0.0376356429815013,0.0515218961386828,0.760165709657904
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,13751,-0.00798924320598975,0.0214684220947366,-0.0500673505116736,0.0340888640996941,0.70979489014222
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,13751,-0.0394526420866026,0.0279020040060801,-0.0941405699385197,0.0152352857653144,0.157392894430009
CCND2,G1/S-specific cyclin-D2,Mental health,X29076.Felt loved as a child,14281,-0.0187522697607213,0.0424524885497001,-0.101959147318134,0.0644546077966909,0.658695863091298
CCND2,G1/S-specific cyclin-D2,Mental health,X29077.Physically abused by family as a child,14304,0.0664617201085107,0.0585174460302898,-0.0482324741108572,0.181155914327879,0.256076462769738
CCND2,G1/S-specific cyclin-D2,Mental health,X29078.Felt hated by family member as a child,14278,0.0323370989408591,0.058977876976598,-0.083259539933273,0.147933737814991,0.583499992530804
CCND2,G1/S-specific cyclin-D2,Mental health,X29079.Sexually molested as a child,14175,0.0310386898821473,0.0787920476712513,-0.123393723553505,0.1854711033178,0.693637355152878
CCND2,G1/S-specific cyclin-D2,Mental health,X29080.Someone to take to doctor when needed as a child,14256,0.0418759207126024,0.0613665076985218,-0.0784024343765003,0.162154275801705,0.495003173701074
CCND2,G1/S-specific cyclin-D2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,14280,-0.0575776622674382,0.0822230368836397,-0.218734814559372,0.103579490024496,0.483775164071267
CCND2,G1/S-specific cyclin-D2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,14202,-0.0798704033902343,0.0631219636372091,-0.203589452119164,0.0438486453386956,0.20577219654719
CCND2,G1/S-specific cyclin-D2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,14292,-0.249773805172274,0.0682851320606698,-0.383612664011187,-0.115934946333361,0.000255297839000586
CCND2,G1/S-specific cyclin-D2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,14245,0.0169718951371801,0.101795472458804,-0.182547230882076,0.216491021156436,0.867588454808206
CCND2,G1/S-specific cyclin-D2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,14247,-0.00321429235774072,0.096036988583624,-0.191446789981644,0.185018205266162,0.973300803430354
CCND2,G1/S-specific cyclin-D2,Mental health,X29086.Experienced a violent or sexual assault,14296,-0.0575047007228112,0.0804755046391301,-0.215236689815506,0.100227288369884,0.474891695026205
CCND2,G1/S-specific cyclin-D2,Mental health,X29087.Experienced a life-threatening injury or illness,14301,0.020348895837133,0.0502885036334763,-0.0782165712844805,0.118914362958746,0.685745933184925
CCND2,G1/S-specific cyclin-D2,Mental health,X29088.Experienced a marital separation or divorce,14301,-0.072151050986235,0.0467074191581143,-0.163697592536139,0.0193954905636691,0.122430111832422
CCND2,G1/S-specific cyclin-D2,Mental health,X29089.Experienced the death of a spouse or partner,14320,-0.0700335859712983,0.0618778874774368,-0.191314245427074,0.0512470734844778,0.257736188748571
CCND2,G1/S-specific cyclin-D2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,14295,-0.0701851143696619,0.0586134638280815,-0.185067503472702,0.0446972747333777,0.231161568322895
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29091.Frequency of drinking alcohol,14302,-0.0114073429856604,0.0386091800297523,-0.0870813358439748,0.0642666498726541,0.767649278368018
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,12722,-0.0535621503439649,0.0445899089046902,-0.140958371797158,0.033834071109228,0.229689483516072
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,12756,-1.58458728171802e-05,0.0453552221564863,-0.0889120812995304,0.088880389553896,0.999721246456354
CCND2,G1/S-specific cyclin-D2,Mental health,X29104.Ever used cannabis,14292,-0.119377857235258,0.0558205560760339,-0.228786147144285,-0.00996956732623173,0.0324849761692958
CCND2,G1/S-specific cyclin-D2,Mental health,X29108.Ever thought that life not worth living,14226,0.0546995938710154,0.0493879306756318,-0.042100750253223,0.151499937995254,0.268075029378862
CCND2,G1/S-specific cyclin-D2,Mental health,X29109.Ever contemplated self-harm,14257,0.0221039768549943,0.0671917396610118,-0.109591832880589,0.153799786590577,0.742184210289211
CCND2,G1/S-specific cyclin-D2,Mental health,X29111.Ever self-harmed,14283,0.0216734855262976,0.110629960781399,-0.195161237605244,0.23850820865784,0.844683612882402
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,14277,0.0221435979940661,0.0718631484792953,-0.118708173025353,0.162995369013485,0.757983615043665
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,14811,-0.040954896453237,0.0293597053778055,-0.0984999189937357,0.0165901260872617,0.163056216554715
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,14811,-0.0158791723641995,0.0230382793608522,-0.0610341999114698,0.0292758551830709,0.490675718097333
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,14811,-0.00213368452449134,0.0243949427234253,-0.049947772262405,0.0456804032134223,0.930303711919432
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,14811,-0.0100589443530622,0.0337627473182359,-0.0762339290968045,0.0561160403906801,0.765760568834191
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,14259,-0.0335156325679004,0.0437322097178571,-0.1192307636149,0.0521994984790996,0.443461002816711
CCND2,G1/S-specific cyclin-D2,Health and medical history,X29153.Pain or discomfort today,14283,-0.0353152506596199,0.0410292827807606,-0.115732644909911,0.0451021435906709,0.389399672757167
CCND2,G1/S-specific cyclin-D2,Mental health,X29154.Anxiety or depression today,14283,0.0489828398385386,0.051921083294837,-0.0527824834193419,0.150748163096419,0.345487495366329
CCND2,G1/S-specific cyclin-D2,Mental health,X29166.Frequency of confiding in someone close,13922,-0.0422667177120996,0.0401970115164768,-0.121052860284394,0.0365194248601949,0.293052306992179
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,14240,0.0117361784723567,0.00694629968293791,-0.00187856890620158,0.025350925850915,0.091134396046318
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,14240,-0.00581286198080638,0.00698494801608112,-0.0195033600923254,0.00787763613071262,0.405310983174445
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,14240,-0.0122363132378399,0.00873138535836556,-0.0293498285402364,0.00487720206455659,0.161111180193268
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,14240,0.000512128283571392,0.00936190438530716,-0.0178372043116306,0.0188614608787734,0.956375504678075
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,14240,-0.026343324412534,0.0150395821779024,-0.0558209054812228,0.00313425665615479,0.0798642484330326
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,14240,-0.00116902241802104,0.00716456794244562,-0.0152115755852144,0.0128735307491724,0.870389116329316
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,14233,-0.00159241755905168,0.00776074077460587,-0.0168034694772792,0.0136186343591758,0.837427509199666
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,14233,-0.00345728178832547,0.0113689366725364,-0.0257403976664968,0.0188258340898458,0.761056951088293
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,14233,-0.00711667650832149,0.0175431404150281,-0.0415012317217765,0.0272678787051335,0.68499325541563
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,14233,0.0241417816032995,0.0157332926211052,-0.00669547193406673,0.0549790351406657,0.12494387872949
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,14233,-0.00748225902203701,0.0231774800450292,-0.0529101199102943,0.0379456018662202,0.746832883944661
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,14233,0.000431103561343162,0.0110516957868109,-0.0212302201808063,0.0220924273034926,0.968884629293728
CCND2,G1/S-specific cyclin-D2,Mental health,X29171.Frequency of feeling 'in tune' with people,13991,0.107278525830621,0.0497818711638691,0.00970605834943755,0.204850993311804,0.0311810721497847
CCND2,G1/S-specific cyclin-D2,Mental health,X29172.Freuency of feeling that lacks companionship,14179,0.0303337784277457,0.0457671958087073,-0.0593699253573205,0.120037482212812,0.50747950084822
CCND2,G1/S-specific cyclin-D2,Mental health,X29173.Frequency of feeling left out,14099,-0.00443542136725332,0.0474420027539364,-0.0974217467649686,0.088550904030462,0.925514476082351
CCND2,G1/S-specific cyclin-D2,Mental health,X29174.Frequency of feeling isolated from others,14156,0.00350764713253249,0.0490624932673825,-0.0926548396715371,0.0996701339366021,0.943006044777821
CCND2,G1/S-specific cyclin-D2,Mental health,X29175.Tendency to bounce back quickly after hard times,14264,-0.0380667654327111,0.0404207746470451,-0.11729148374092,0.0411579528754974,0.346330271491585
CCND2,G1/S-specific cyclin-D2,Mental health,X29176.Ability to make it through stressful events,14264,0.0458890229840101,0.0392306897558112,-0.0310031289373798,0.1227811749054,0.242132203007981
CCND2,G1/S-specific cyclin-D2,Mental health,X29177.Quick recovery from stressful events,14264,-0.0654008695198041,0.0399184885981085,-0.143641107172097,0.0128393681324886,0.101368624163146
CCND2,G1/S-specific cyclin-D2,Mental health,X29178.Hard to snap back when something bad happens,14264,0.0343754108705077,0.0398764487087189,-0.0437824285985813,0.112533250339597,0.388675641116475
CCND2,G1/S-specific cyclin-D2,Mental health,X29179.Comes through difficult times with little trouble,14264,-0.0658643327433285,0.0397772864916952,-0.143827814267051,0.0120991487803942,0.0977787399409339
CCND2,G1/S-specific cyclin-D2,Mental health,X29180.Tendency to take a long time to get over setbacks,14264,0.050383737508365,0.0395007557519178,-0.0270377437653938,0.127805218782124,0.202148432801926
CCND2,G1/S-specific cyclin-D2,Mental health,X29181.General happiness,14183,0.0579902917485594,0.0411921467810331,-0.0227463159422654,0.138726899439384,0.159212334710784
CCND2,G1/S-specific cyclin-D2,Mental health,X29182.Belief that own life is meaningful,14013,-0.0749098243601329,0.0412806242681193,-0.155819847925647,0.00600019920538095,0.0695993366839174
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,9803,-0.0209500002224454,0.0483554191531561,-0.115726621762631,0.0738266213177406,0.664842481686969
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2946.Father's age,9516,-0.000708325539053217,0.00593421188877656,-0.0123393808410553,0.0109227297629489,0.90499026934397
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2966.Age high blood pressure diagnosed,10901,-0.00685934157306698,0.0046027236535029,-0.0158806799339327,0.00216199678779869,0.136179908898304
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30000.White blood cell (leukocyte) count,42517,0.00604667851994773,0.00195193434402384,0.00222088720566101,0.00987246983423445,0.00195097977849477
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,42518,0.00123421183466175,0.00219805560743123,-0.00307397715590346,0.00554240082522695,0.574458571116357
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30020.Haemoglobin concentration,42518,-0.00271663296667992,0.00235827819036105,-0.00733885821978757,0.00190559228642773,0.249345589223875
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30030.Haematocrit percentage,42518,-0.000239481347537542,0.00230338952289833,-0.00475412481241828,0.00427516211734319,0.917194356715036
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30040.Mean corpuscular volume,42518,-0.00220146731577174,0.00192759805875922,-0.00597955951093981,0.00157662487939632,0.253428037118418
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,42517,-0.00492813475608098,0.00193279864974297,-0.00871642010957721,-0.00113984940258476,0.0107837951790692
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,42517,-0.005267536187111,0.00189155088064434,-0.00897497591317391,-0.0015600964610481,0.00535892166001936
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,42518,0.00578729363933973,0.00188247327169108,0.00209764602682522,0.00947694125185423,0.002111285577051
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30080.Platelet count,42518,-0.00130446053086231,0.00192958815406719,-0.00508645331283401,0.00247753225110939,0.499024930490913
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30090.Platelet crit,42518,-0.00196739826152914,0.0019735840841178,-0.00583562306640003,0.00190082654334175,0.318835382038223
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,42518,-0.000618922319627937,0.00184969811994153,-0.00424433063471334,0.00300648599545746,0.737923059520135
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30110.Platelet distribution width,42518,-0.00138622140685016,0.00187625137921913,-0.00506367411011965,0.00229123129641934,0.46001735468894
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30120.Lymphocyte count,42453,0.0163341061606241,0.00191713857509474,0.0125765145534384,0.0200916977678098,1.64654349034491e-17
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30130.Monocyte count,42453,0.0103823549960094,0.00194268338199464,0.00657469556729993,0.0141900144247189,9.12157308599382e-08
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30140.Neutrophill count,42453,-0.00318846967803953,0.00193184383391524,-0.00697488359251341,0.000597944236434339,0.0988521932573106
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30150.Eosinophill count,42453,0.0136027164271949,0.00187541331440982,0.00992690633095169,0.0172785265234382,4.14028930494971e-13
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30160.Basophill count,42453,0.0729279121294359,0.025830997348119,0.0222991573271226,0.123556666931749,0.00475584612288012
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30170.Nucleated red blood cell count,42453,-0.0247130229313995,0.123424519420913,-0.266625080996388,0.217199035133589,0.841303366922586
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30180.Lymphocyte percentage,42454,0.0135332918578956,0.0018903656312466,0.00982817522065229,0.017238408495139,8.25310169417989e-13
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30190.Monocyte percentage,42454,0.00644285722656158,0.00191873130864081,0.00268214386162559,0.0102035705914976,0.000786135286229073
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30200.Neutrophill percentage,42454,-0.0163974746406743,0.0018716142484921,-0.0200658385677188,-0.0127291107136298,2.00282810773511e-18
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30210.Eosinophill percentage,42454,0.0113586649064736,0.00185649192123627,0.00771994074085055,0.0149973890720967,9.53748250702573e-10
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30220.Basophill percentage,42454,0.00510471828829998,0.00185674526508499,0.00146549756873341,0.00874393900786655,0.00597510464500368
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30230.Nucleated red blood cell percentage,42453,-0.0274365809500714,0.123400746177634,-0.269302043458233,0.214428881558091,0.824052436440611
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30240.Reticulocyte percentage,41735,-0.000686588732356426,0.00200120275468653,-0.00460894613154203,0.00323576866682918,0.731533956392
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30250.Reticulocyte count,41735,-0.000234741241291159,0.00204600406261851,-0.00424490920402344,0.00377542672144112,0.908658448625202
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30260.Mean reticulocyte volume,41735,-0.000467148512743975,0.0019039843964682,-0.00419895792982164,0.00326466090433369,0.806184231081996
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30270.Mean sphered cell volume,41735,-0.00110295906555617,0.00191998180733834,-0.00486612340793931,0.00266020527682697,0.565657432643065
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30280.Immature reticulocyte fraction,41735,0.00233624345370351,0.00199736764730008,-0.00157859713500464,0.00625108404241166,0.242144017186664
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,41735,0.000645446561169287,0.00204272862907714,-0.00335830155182191,0.00464919467416048,0.75202478018327
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30300.High light scatter reticulocyte count,41735,0.000890664621557553,0.00207454305785501,-0.00317543977183826,0.00495676901495337,0.667684936098979
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30500.Microalbumin in urine,13800,0.00287748486562358,0.00334841172503881,-0.00368540211545249,0.00944037184669965,0.390157900252686
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,42599,-0.00241716091168078,0.00201701133614983,-0.00637050313053444,0.00153618130717288,0.230772915914055
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30520.Potassium in urine,42519,-0.00137568639151039,0.00187911508017523,-0.00505875194865383,0.00230737916563306,0.464116038986899
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30530.Sodium in urine,42499,0.00528267245468075,0.00196194504800145,0.0014372601605979,0.0091280847487636,0.0070931655058563
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30600.Albumin,38278,0.00391706562628255,0.00202328635920704,-4.85756377632488e-05,0.00788270689032835,0.0528760716562919
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30610.Alkaline phosphatase,41775,0.0120070660124161,0.00194461993163114,0.00819561094641905,0.0158185210784131,6.69808616009441e-10
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30620.Alanine aminotransferase,41769,0.0154481528005579,0.00205402276957396,0.011422268172193,0.0194740374289229,5.5477972806888e-14
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30630.Apolipoprotein A,38025,0.00667729114766319,0.00222653730781014,0.00231327802435531,0.0110413042709711,0.00271080235465407
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30640.Apolipoprotein B,41542,0.00731958357902274,0.00188140441585178,0.00363203092395325,0.0110071362340922,0.000100198227811584
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30650.Aspartate aminotransferase,41650,0.0260476523532788,0.00194433584482295,0.0222367540974258,0.0298585506091318,7.683837889734e-41
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30660.Direct bilirubin,35411,-0.00720383982613398,0.00213103494499099,-0.0113806683183163,-0.00302701133395164,0.000724475327403386
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30670.Urea,41762,0.0112776037367439,0.00200045004151585,0.00735672165537287,0.015198485818115,1.73614513677893e-08
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30680.Calcium,38270,-0.00311598698364947,0.00196579629892865,-0.00696894772954962,0.000736973762250682,0.112951503119995
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30690.Cholesterol,41788,0.0134261834698325,0.00190973862476738,0.00968309576528844,0.0171692711743766,2.09129100610617e-12
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30700.Creatinine,41774,0.0142699988230418,0.00235061937103643,0.00966278485581036,0.0188772127902731,1.28417120316851e-09
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30710.C-reactive protein,41658,0.00179182115588179,0.00210018717355033,-0.00232454570427685,0.00590818801604044,0.393568765532353
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30720.Cystatin C,41791,0.0102601618927693,0.00222710615637638,0.00589503382627164,0.014625289959267,4.09827340946471e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30730.Gamma glutamyltransferase,41773,0.00494174425944865,0.00209700780273245,0.000831608966093053,0.00905187955280425,0.0184492163972342
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30740.Glucose,38228,-0.00181390246808153,0.00202102190701483,-0.00577510540583059,0.00214730046966754,0.369448510107193
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),41607,0.0169291926473244,0.00202655515289795,0.0129571445476444,0.0209012407470043,6.81885729216395e-17
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30760.HDL cholesterol,38248,0.0113670277164746,0.00231592649912009,0.00682781177819925,0.01590624365475,9.22945718570819e-07
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30770.IGF-1,41568,-0.00914730470027831,0.00197250263625107,-0.0130134098673304,-0.00528119953322621,3.53873743829072e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30780.LDL direct,41696,0.0101491564233593,0.0018837487017934,0.00645700896784419,0.0138413038788743,7.17333897536556e-08
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30790.Lipoprotein A,33445,0.00305918857073979,0.00210416804925064,-0.00106498080579146,0.00718335794727104,0.14599150583454
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30810.Phosphate,38189,0.00501158722581324,0.00202953254528819,0.00103370343704839,0.00898947101457809,0.0135409442431471
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30830.SHBG,37921,-0.00174771132477024,0.00233861011450545,-0.00633138714920093,0.00283596449966045,0.454869583940476
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30840.Total bilirubin,41628,-0.00705625104462907,0.00199998102896777,-0.0109762138614059,-0.00313628822785224,0.000418911516951416
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30850.Testosterone,37734,-0.00158988603645747,0.00324946395075631,-0.00795883537993983,0.00477906330702489,0.62464886909709
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30860.Total protein,38244,-0.000218231053017524,0.00199599918083968,-0.00413038944746331,0.00369392734142826,0.912937963808927
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30870.Triglycerides,41761,0.00437767090163891,0.00204447491078385,0.000370500076502575,0.00838484172677525,0.0322620601465184
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30880.Urate,41728,0.00626837749723794,0.00236915253643814,0.00162483852581918,0.0109119164686567,0.00815210522676679
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30890.Vitamin D,39888,0.00407315835713358,0.00212464274116739,-9.11414155545034e-05,0.00823745812982166,0.0552320222919486
CCND2,G1/S-specific cyclin-D2,Physical measures,X3137.Number of measurements made,39704,0.0138169369180591,0.0299614171138043,-0.0449074406249973,0.0725413144611155,0.644688025225525
CCND2,G1/S-specific cyclin-D2,Physical measures,X3143.Ankle spacing width,24726,-0.000487772868894043,0.00342959399818034,-0.00720977710532752,0.00623423136753943,0.886903706784472
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",24725,0.000702342460935079,0.00263737468182816,-0.00446691191544811,0.00587159683731827,0.79000759678837
CCND2,G1/S-specific cyclin-D2,Physical measures,X3146.Speed of sound through heel,24726,-3.07519521260741e-05,0.00255637518372607,-0.00504124731222917,0.00497974340797702,0.990402164765492
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",24726,0.000230940331895548,0.00258102937224528,-0.0048278772377052,0.0052897579014963,0.928704305896144
CCND2,G1/S-specific cyclin-D2,Physical measures,X3148.Heel bone mineral density (BMD),24705,0.000429922632547484,0.00258750837922269,-0.00464159379072899,0.00550143905582396,0.868037798936823
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3526.Mother's age at death,26158,0.001528308,0.002449014,-0.003271761,0.006328376,0.5326002
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3581.Age at menopause (last menstrual period),13591,-0.00296281202518903,0.0033577949408828,-0.00954409010931932,0.00361846605894127,0.377593258870051
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",8627,0.00139580750249389,0.00432270068430608,-0.00707668583874603,0.00986830084373382,0.746777509070746
CCND2,G1/S-specific cyclin-D2,Physical measures,X4100.Ankle spacing width (left),14282,-0.00428236913703472,0.00431115022306884,-0.0127322235742497,0.00416748530018021,0.32056891310475
CCND2,G1/S-specific cyclin-D2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),14279,-0.00500746322314868,0.003306849554452,-0.0114888883498746,0.00147396190357724,0.129979518044198
CCND2,G1/S-specific cyclin-D2,Physical measures,X4103.Speed of sound through heel (left),14282,-0.00324864350522656,0.00320700835478224,-0.00953437988059975,0.00303709287014663,0.31108567278348
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",14282,-0.00386282833268999,0.00323790375590792,-0.0102091196942695,0.00248346302888953,0.232888103886954
CCND2,G1/S-specific cyclin-D2,Physical measures,X4105.Heel bone mineral density (BMD) (left),14274,-0.00356211629072313,0.00323655327755032,-0.00990576071472176,0.0027815281332755,0.271093970632167
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",14282,-0.00386149203616175,0.00323791263056438,-0.0102078007920679,0.00248481671974443,0.233051049612009
CCND2,G1/S-specific cyclin-D2,Physical measures,X4119.Ankle spacing width (right),14268,-0.00166207151810477,0.00425032869050349,-0.00999271575149161,0.00666857271528206,0.695769516520524
CCND2,G1/S-specific cyclin-D2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),14267,-0.00423495612532014,0.0033182917577366,-0.0107388079704839,0.0022688957198436,0.201889416537029
CCND2,G1/S-specific cyclin-D2,Physical measures,X4122.Speed of sound through heel (right),14268,-0.00340097173048826,0.00320739099258408,-0.00968745807595305,0.00288551461497654,0.289001283527454
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",14268,-0.00355547402816423,0.00324344792705652,-0.009912631965195,0.00280168390886654,0.27300891479743
CCND2,G1/S-specific cyclin-D2,Physical measures,X4124.Heel bone mineral density (BMD) (right),14257,-0.00329374421303218,0.00324550864816963,-0.00965494116344465,0.0030674527373803,0.310188733598596
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",14268,-0.00355892007437364,0.00324345851648406,-0.0099160987666824,0.00279825861793512,0.272545912139614
CCND2,G1/S-specific cyclin-D2,Physical measures,X4194.Pulse rate,14850,-0.00286717210250071,0.00311515298008566,-0.00897287194346861,0.00323852773846719,0.357381198744177
CCND2,G1/S-specific cyclin-D2,Physical measures,X4195.Pulse wave reflection index,14850,-0.00148745380298708,0.00317192424826418,-0.00770442532958487,0.0047295177236107,0.639116789873446
CCND2,G1/S-specific cyclin-D2,Physical measures,X4196.Pulse wave peak to peak time,14839,0.000876557410982664,0.00315805477435034,-0.00531322994674399,0.00706634476870932,0.781352133001753
CCND2,G1/S-specific cyclin-D2,Physical measures,X4198.Position of the pulse wave peak,14850,0.00495204181020262,0.00319115791553626,-0.00130262770424845,0.0112067113246537,0.120731194417912
CCND2,G1/S-specific cyclin-D2,Physical measures,X4199.Position of pulse wave notch,14850,2.78316288648881e-05,0.00309342992043197,-0.00603529101518177,0.00609095427291154,0.992821640137338
CCND2,G1/S-specific cyclin-D2,Physical measures,X4200.Position of the shoulder on the pulse waveform,14850,0.00213745820558221,0.00320678459070592,-0.0041478395922014,0.00842275600336581,0.505074775295688
CCND2,G1/S-specific cyclin-D2,Physical measures,X4269.Number of triplets attempted (left),14559,-0.147033102627969,0.132032695450888,-0.405817185711709,0.111750980455771,0.265464393423741
CCND2,G1/S-specific cyclin-D2,Physical measures,X4270.Volume level set by participant (left),14404,-0.093323171080212,0.0413095070073687,-0.174289804814655,-0.0123565373457693,0.0238907665153756
CCND2,G1/S-specific cyclin-D2,Physical measures,X4276.Number of triplets attempted (right),14566,0.057412498111158,0.127479892408772,-0.192448091010035,0.307273087232351,0.65245390026315
CCND2,G1/S-specific cyclin-D2,Physical measures,X4277.Volume level set by participant (right),14400,-0.133075484211378,0.0412198759867374,-0.213866441145383,-0.0522845272773725,0.00124750846222235
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4288.Time to answer,14878,0.00166805379886724,0.00361732240596035,-0.00542189811681504,0.00875800571454952,0.644712499487279
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4290.Duration screen displayed,14878,-0.0035000279456259,0.00325080245249479,-0.00987160075251569,0.00287154486126389,0.281647053656455
CCND2,G1/S-specific cyclin-D2,Physical measures,X46.Hand grip strength (left),43723,0.00564477532321577,0.00265418730600943,0.000442568203437289,0.0108469824429943,0.0334469950418586
CCND2,G1/S-specific cyclin-D2,Physical measures,X47.Hand grip strength (right),43722,0.00414324147454032,0.00263353087456581,-0.00101847903960867,0.00930496198868931,0.115664749959687
CCND2,G1/S-specific cyclin-D2,Physical measures,X48.Waist circumference,43852,-0.01436669,0.004087646,-0.02237848,-0.006354904,0.0004407594
CCND2,G1/S-specific cyclin-D2,Health and medical history,X4803.Tinnitus,14593,0.0492611241795097,0.0485362201244377,-0.0458698672643882,0.144392115623408,0.310153506000893
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4825.Noisy workplace,14793,0.00618801532201527,0.0547932209423791,-0.101206697725048,0.113582728369078,0.910084447897066
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4836.Loud music exposure frequency,14699,0.0467267716469772,0.069831155248102,-0.0901422926393028,0.183595835933257,0.503417131173431
CCND2,G1/S-specific cyclin-D2,Physical measures,X49.Hip circumference,43843,-0.000824152276788066,0.00327407164608189,-0.00724133270310857,0.00559302814953244,0.801257977784445
CCND2,G1/S-specific cyclin-D2,Physical measures,X50.Standing height,43806,-0.0030834992857495,0.0025978937351853,-0.0081753710067127,0.00200837243521369,0.235264514732228
CCND2,G1/S-specific cyclin-D2,Health and medical history,X5057.Number of older siblings,13066,-0.0634802072154742,0.0440552672254105,-0.149828530977279,0.0228681165463304,0.149630688313767
CCND2,G1/S-specific cyclin-D2,Physical measures,X51.Seated height,43614,-0.00220403731021536,0.00241985547110549,-0.00694695403358211,0.0025388794131514,0.362398622736024
CCND2,G1/S-specific cyclin-D2,Eye measures,X5181.Ever had eye surgery,10059,-0.0757635341230337,0.0998774126107479,-0.2715232628401,0.119996194594032,0.448130469833713
CCND2,G1/S-specific cyclin-D2,Eye measures,X5186.Duration visual-acuity screen displayed (right),10035,-0.000875068438349992,0.00379293513786126,-0.00830922130855805,0.00655908443185807,0.817544737581772
CCND2,G1/S-specific cyclin-D2,Eye measures,X5188.Duration visual-acuity screen displayed (left),10033,-0.002712536130885,0.00383177085729618,-0.0102228070111855,0.00479773474941551,0.47901968743086
CCND2,G1/S-specific cyclin-D2,Eye measures,X5190.Duration at which refractometer first shown (right),9920,-0.000850117240549425,0.00385742136293912,-0.00841066311191011,0.00671042863081126,0.825575982478676
CCND2,G1/S-specific cyclin-D2,Eye measures,X5193.Duration at which refractometer first shown (left),9917,-0.00335957805115795,0.00388566205041744,-0.0109754756699761,0.00425631956766022,0.387274419787373
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5199.logMAR, initial (right)",9996,-0.0505464360676556,0.0518763628514931,-0.152224107256582,0.0511312351212708,0.329899683879976
CCND2,G1/S-specific cyclin-D2,Eye measures,X5200.Final number of letters displayed (right),9996,-0.0216438751656395,0.346618664598823,-0.701016457779333,0.657728707448054,0.950211381524483
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5201.logMAR, final (right)",9900,-0.000817972307824502,0.00385129458831749,-0.00836650970092678,0.00673056508527778,0.831808005987208
CCND2,G1/S-specific cyclin-D2,Eye measures,X5202.Number of rounds to result (right),9996,-0.0847221094610314,0.0489383953079506,-0.180641364264615,0.0111971453425518,0.0834471802443697
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5206.logMAR, initial (left)",9992,0.0462102711912286,0.0517339042444983,-0.055188181127988,0.147608723510445,0.371755602455995
CCND2,G1/S-specific cyclin-D2,Eye measures,X5207.Final number of letters displayed (left),9992,0.21733077492407,0.313479359079131,-0.397088768871027,0.831750318719167,0.48814637941643
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5208.logMAR, final (left)",9901,0.00117532375298696,0.0038623142231601,-0.00639481212440684,0.00874545963038076,0.760901502041351
CCND2,G1/S-specific cyclin-D2,Eye measures,X5209.Number of rounds to result (left),9986,-0.004874809140405,0.0489367944773048,-0.100790926315922,0.0910413080351124,0.920652470275562
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",9573,0.0046154466287097,0.00383593114764314,-0.00290297842067086,0.0121338716780903,0.228923259545525
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",9573,0.00592933696917367,0.00381567237373895,-0.00154938088335466,0.013408054821702,0.120231144381907
CCND2,G1/S-specific cyclin-D2,Eye measures,X5256.Corneal hysteresis (right),9573,0.000217783640932407,0.00386052261607322,-0.0073488406865711,0.00778440796843591,0.95501398440691
CCND2,G1/S-specific cyclin-D2,Eye measures,X5257.Corneal resistance factor (right),9573,0.00361577745580709,0.00383348450549305,-0.00389785217495929,0.0111294070865735,0.345597799135251
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",9540,0.00818732205184411,0.0038520132284512,0.000637376124079755,0.0157372679796085,0.0335734301116923
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",9540,0.00586075509317073,0.00381402544584754,-0.00161473478069044,0.0133362449670319,0.124416564435121
CCND2,G1/S-specific cyclin-D2,Eye measures,X5264.Corneal hysteresis (left),9540,-0.00603800398799167,0.00387855199096205,-0.0136399658902773,0.00156395791429394,0.119558897413085
CCND2,G1/S-specific cyclin-D2,Eye measures,X5265.Corneal resistance factor (left),9540,-0.00188168698051575,0.00384213869385161,-0.0094122788204649,0.00564890485943339,0.624322175571682
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,9933,0.182445342017479,0.2444031723755,-0.296584875838501,0.661475559873459,0.455387143417491
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",43727,-0.00537193822500249,0.0105208270605264,-0.0259927592636343,0.0152488828136293,0.609633492804529
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",43727,-0.00962858656911318,0.0114342995246661,-0.0320398136374588,0.0127826404992325,0.399748192167224
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",43727,0.00712589643698573,0.0109615737964914,-0.0143587882041373,0.0286105810781088,0.515644167320652
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",43727,-0.00840962410170061,0.00468824141063222,-0.0175985772665398,0.00077932906313855,0.0728568877965647
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",43727,0.00840244146325595,0.00431678908118286,-5.84651358624521e-05,0.0168633480623744,0.0516063457184926
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",19747,-0.00743316229985295,0.00541240357648159,-0.0180414733097569,0.00317514871005097,0.169656996021413
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",19747,-0.0205668029898928,0.0144892121765273,-0.0489656588558863,0.0078320528761007,0.155781835080138
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",19747,-0.0114760218165275,0.0105096355919779,-0.0320749075768042,0.00912286394374914,0.274867355030114
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",19747,0.0124624376095506,0.00640741664629514,-9.60990171878281e-05,0.0250209742362891,0.0517889339827696
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,43857,-0.00175997045146385,0.00721219866701561,-0.0158958798388145,0.0123759389358868,0.807211131607646
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,43857,0.00287558124869998,0.00922611209116192,-0.0152075984499774,0.0209587609473774,0.755286312302927
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),43857,-0.00516617524970371,0.00713886778942976,-0.019158356116986,0.00882600561757863,0.469273007804083
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',43857,-0.00836823862809866,0.011630934461969,-0.0311648701735579,0.0144283929173605,0.471848319607174
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),43857,-0.0100231200219558,0.0285813070880769,-0.0660424819145864,0.0459962418706749,0.725824150708612
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),43857,0.0151124415655488,0.0197186411410391,-0.0235360950708878,0.0537609782019854,0.443440196887022
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,43857,0.0361201826110708,0.0308169226194156,-0.0242809857229838,0.0965213509451254,0.241167608789306
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,43726,-0.0042891461955692,0.00601009950580446,-0.016068941226946,0.00749064883580754,0.475443460690344
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,43726,0.0014376915245656,0.0102181191980144,-0.0185898221035425,0.0214652051526737,0.888107426920184
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,43726,-0.00376208131353032,0.00538835774760342,-0.014323262498833,0.00679909987177239,0.485063971366466
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,43726,-0.0012693840567164,0.00897398642154837,-0.0188583974429512,0.0163196293295184,0.887513904899586
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,43726,-0.00564338778322805,0.00892084308798182,-0.0231282402356724,0.0118414646692163,0.526993623781749
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,43726,-0.00496394723740164,0.00502042821417592,-0.0148039865371864,0.00487609206238317,0.322791058865475
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,13519,0.00504094425661736,0.0121859539537873,-0.0188435254928057,0.0289254140060404,0.679123530265436
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,13519,0.00317610260225678,0.0104637935765318,-0.0173329328077456,0.0236851380122592,0.761488673530516
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,13519,-0.00546631093574089,0.0143786125351378,-0.033648391504611,0.0227157696331292,0.703825525163445
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,13519,0.00290453745629437,0.0114361828385332,-0.0195103809072306,0.0253194558198193,0.799516514711174
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,43675,-0.00636655657797424,0.0152393995724283,-0.0362357797399336,0.0235026665839851,0.676117695578659
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,43675,0.0347809436194745,0.0230090629358019,-0.0103168197346972,0.0798787069736463,0.130637976218864
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,43675,-0.00447492408618361,0.0403750524103944,-0.0836100268105566,0.0746601786381894,0.911748580625628
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,43675,-0.0070670309547084,0.0384610953500646,-0.082450777840835,0.0683167159314182,0.854214419665667
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,43675,-0.0117577594188212,0.0131888541530459,-0.0376079135587912,0.0140923947211489,0.372670135218261
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,43675,-0.00887579853418094,0.01768010065616,-0.0435287958202546,0.0257771987518927,0.615654615390773
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,43675,0.00515379386730421,0.00815685874244347,-0.010833649267885,0.0211412370024934,0.527497606230108
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",14182,0.0207155632074462,0.0130349764690576,-0.00483299067190678,0.0462641170867992,0.112031004136548
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",14182,0.000561701111654298,0.0137857843043785,-0.0264584361249277,0.0275818383482362,0.967499799404236
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",14182,-0.00874084758857486,0.0189703412235,-0.0459227163866349,0.0284410212094852,0.644975107445526
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",14182,0.00333087021703964,0.00666125919019107,-0.00972519779573485,0.0163869382298141,0.617057408634191
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",19861,-0.00151535344230932,0.00621177338402407,-0.0136904292749965,0.0106597223903779,0.807273147415831
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",19861,0.00526314646983567,0.00604299606679495,-0.00658112582108243,0.0171074187607538,0.383792075037221
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",19861,-0.000536591590071783,0.00553977440252828,-0.0113945494190272,0.0103213662388836,0.922837256668186
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",19862,-0.008823404594284,0.0131309305124939,-0.0345600283987719,0.0169132192102039,0.501619672239106
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",19862,-0.00659067944494953,0.00781798798555207,-0.0219139358966316,0.00873257700673253,0.39923033485734
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",19862,-0.0273086440452118,0.0106082499553524,-0.0481008139577025,-0.00651647413272103,0.0100519710523643
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,43726,0.00766486235010457,0.0125643209276274,-0.0169612066680452,0.0322909313682543,0.541831943911864
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,43726,0.00472267955998163,0.00880486986839382,-0.0125348653820702,0.0219802245020335,0.59170468711552
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,43726,-0.0141000102513027,0.0253542993513094,-0.0637944369798691,0.0355944164772636,0.578132282280715
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,43726,-0.000942755021560793,0.00902452059132273,-0.0186308153805533,0.0167453053374318,0.916800076030301
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,43726,0.0152143509986879,0.0102827643998932,-0.0049398672251029,0.0353685692224786,0.138987939529262
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),43726,0.00524457501727359,0.0118335777193406,-0.017949237312634,0.0284383873471812,0.657627344409249
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,43726,-0.00502779609392042,0.00391204491057783,-0.012695404118653,0.00263981193081213,0.198726000415171
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,8555,0.00450495620707167,0.0114105521178428,-0.0178597259439002,0.0268696383580436,0.692995810705431
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,8555,-0.00242066978944614,0.014360043198694,-0.0305663544588863,0.0257250148799941,0.866139018413966
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,8555,0.00457137014600737,0.0101746696360266,-0.0153709823406047,0.0245137226326194,0.653234379382027
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,8555,-0.0170414026069908,0.00911915002882781,-0.0349149366634933,0.000832131449511716,0.0616919448941377
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,43920,0.00197799981271203,0.00457795369621548,-0.0069947894318703,0.0109507890572944,0.665692126426451
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,43920,0.00666730286454897,0.0132036766777174,-0.0192119034237771,0.0325465091528751,0.613590832927108
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,43920,-0.00609489760857123,0.00428639123954922,-0.0144962244380877,0.00230642922094525,0.155057109629176
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,43920,-0.00700448213246546,0.00414859281229965,-0.0151357240445728,0.00112675977964187,0.0913416631536736
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,43920,0.00244415609588234,0.00644100043022231,-0.0101802047473534,0.0150685169391181,0.704341904673774
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,43920,-0.00777614302738786,0.00571377704109278,-0.0189751460279297,0.00342285997315398,0.173537683951689
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,43920,-0.0075932415184944,0.00446319344768515,-0.0163411006759573,0.00115461763896849,0.0888933066993667
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,43920,0.0080808009896363,0.0130361199857655,-0.0174699941824641,0.0336315961617367,0.53534147901511
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,30408,-0.00467231060973438,0.00449990624315787,-0.0134921268463238,0.00414750562685505,0.299132674266167
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,30408,0.00177200323131809,0.00470250967582749,-0.00744491573330378,0.01098892219594,0.706309448529753
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,30408,0.0148118761537097,0.00529085842135181,0.00444179364786012,0.0251819586595592,0.00512105442299236
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,30409,-0.00579486774995789,0.00722495392209845,-0.0199557774372708,0.00836604193735507,0.422522824507546
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,30409,-0.0120962306955537,0.00475363205226398,-0.0214133495179911,-0.00277911187311626,0.0109442861228878
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,43525,-0.0119033584991529,0.00460616530123035,-0.0209314424895644,-0.00287527450874144,0.00976309219288961
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,43525,0.00572165041694592,0.00367456387815668,-0.00148049478424117,0.012923795618133,0.119454857747581
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,43525,0.00271282950449507,0.00407345588986366,-0.0052711440396377,0.0106968030486278,0.505429085719808
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,43525,0.0160621978830992,0.0073848380649453,0.00158791527580646,0.030536480490392,0.0296337063047569
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),43554,-0.00679548945483243,0.00405371635588077,-0.0147407735123587,0.00114979460269387,0.0936748055589121
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,43554,-0.00479622056446037,0.00634796985825038,-0.0172382414866311,0.00764580035771038,0.449922002883598
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),43726,0.00424863161414478,0.0039979529199062,-0.00358735610887138,0.0120846193371609,0.287923092205759
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,43726,0.00224083141346779,0.00473479729230213,-0.00703937127944439,0.01152103410638,0.636023844991151
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,43726,-0.00336178551966587,0.00709424918728865,-0.0172665139267516,0.0105429428874199,0.635591596876719
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,43726,0.000735098535501828,0.00912729554961413,-0.0171544007417419,0.0186245978127455,0.935809359496379
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,43726,-0.0126768947930467,0.0098856171164316,-0.0320527043412527,0.0066989147551592,0.199724082409812
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,43726,0.0223889802314764,0.0117506451645863,-0.000642284291112682,0.0454202447540655,0.056742377724056
CCND2,G1/S-specific cyclin-D2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",24726,0.000230391655149515,0.00258103299363649,-0.00482843301237801,0.00528921632267704,0.928873342459557
CCND2,G1/S-specific cyclin-D2,Physical activities,X864.Number of days or week walked 10+ minutes,42981,0.00754372871763988,0.0234780463899298,-0.0384732422066225,0.0535606996419022,0.747977118474388
CCND2,G1/S-specific cyclin-D2,Physical activities,X874.Duration of walks,37199,0.00575539393495699,0.00196339850920559,0.00190713285691404,0.00960365501299995,0.0033770565689495
CCND2,G1/S-specific cyclin-D2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,41523,0.0835020738637762,0.022582617726773,0.0392401431193011,0.127764004608251,0.000217905436006996
CCND2,G1/S-specific cyclin-D2,Physical activities,X894.Duration of moderate activity,32167,0.0600722841088543,0.0274208610564502,0.00632739643821188,0.113817171779497,0.0284769551731477
CCND2,G1/S-specific cyclin-D2,Physical activities,X90087.No-wear time bias adjusted average acceleration,8978,0.0178967657840147,0.00430730437411373,0.00945444921075181,0.0263390823572776,3.28336627591417e-05
CCND2,G1/S-specific cyclin-D2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,41485,0.056815666994517,0.0231793569121842,0.011384127446636,0.102247206542398,0.0142448637382089
CCND2,G1/S-specific cyclin-D2,Physical activities,X914.Duration of vigorous activity,23218,0.00128788400298947,0.0025030420975124,-0.00361807850813484,0.00619384651411378,0.606888136442343
